Focal epilepsy, mode (most common among epilepsy diagnosis)

FE_MODE

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %3453, %345[4-5], %G40[0-2] Registry filters: Hospital discharge: ICD-10 — G40.0, G40.1, G40.2 Hospital discharge: ICD-9 — %345[4-5] Hospital discharge: ICD-8 — %3453 Cause of death: ICD-10 — G40.0, G40.1, G40.2 Cause of death: ICD-9 — %345[4-5] Cause of death: ICD-8 — %3453 2 out of 7 registries used, show all original rules.	9834
4. Check minimum number of events None	9834
5. Include endpoints None	9834
6. Filter based on genotype QC (FinnGen only)	8805

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze: DF11

NAME	FE_MODE
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%G40[0-2]
HD_ICD_9	%345[4-5]
HD_ICD_8	%3453
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%G40[0-2]
COD_ICD_9	%345[4-5]
COD_ICD_8	%3453
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy, mode (most common among epilepsy diagnosis) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8805	4393	4412
Unadjusted period prevalence (%)	1.79	1.56	2.02
Median age at first event (years)	55.19	50.30	60.06

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9072: Matched controls
90683

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

97.6

313.8

163

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.1

307.7

1877

4430

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

3953

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

11.2

307.7

591

562

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5184.0

307.7

953

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

307.7

1558

N03AX11

ATC

topiramate; oral

8.5

307.7

579

725

N03AX15

ATC

zonisamide; oral

67.4

307.7

230

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

4861.4

307.7

472

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.3

307.7

2673

10130

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

18.0

307.7

508

298

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

3400.5

307.7

338

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

307.7

453

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.0

307.7

1516

3469

N88

ICPC

Epilepsy

941.6

307.7

697

ZXC95

NOMESCO Finland

Use of surgical navigator

11.9

307.7

370

322

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

16.5

307.7

440

279

N03AB02

ATC

phenytoin; systemic

59.7

307.7

696

126

N03AX09

ATC

lamotrigine; oral

8.6

307.7

1287

1718

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.8

307.7

876

1088

XA400

NOMESCO Finland

EEG

22.4

307.7

249

114

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

7526

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

45.2

307.7

686

164

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

30.8

307.7

278

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

92.4

307.7

243

N03AF01

ATC

carbamazepine; oral, rectal

19.3

307.7

2170

1454

AA1AD

NOMESCO Finland

CT of head and brain

5.1

307.7

4912

16961

G40.9

ICD-10 Finland

Epilepsy, unspecified

1527.6

307.7

3242

G41.9

ICD-10 Finland

Status epilepticus, unspecified

126.7

307.7

446

N03AX23

ATC

brivaracetam; systemic

+∞

307.7

371

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3337.7

307.7

643

N03AX14

ATC

levetiracetam; systemic

254.4

307.7

3710

246

XA800

NOMESCO Finland

Neuropsychological investigation

8.0

307.7

1157

1632

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

16384.0

307.7

3435

R56.8

ICD-10 Finland

Other and unspecified convulsions

41.1

307.7

3407

1308

N05BA01

ATC

diazepam; systemic, rectal

3.5

307.7

1853

6212

N03AG01

ATC

valproic acid; systemic, rectal

25.8

307.7

3063

1755

G40

ICD-10 Finland

Epilepsy

1036.9

307.7

931

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

168.0

307.7

165

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

307.7

1117

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.5

307.7

1539

4958

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

1119

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.6

307.7

1538

4921

N03AF02

ATC

oxcarbazepine; oral

175.4

307.7

3864

382

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.8

307.7

2286

3768

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

307.7

329

N03AX18

ATC

lacosamide; systemic

1145.2

307.7

1194

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

14.3

307.7

327

236

N05BA09

ATC

clobazam; oral

393.6

307.7

791

G40.10

ICD-10 Finland

Simple partial seizures

13128.5

307.7

1159

G40.89

ICD-10 Finland

Other epilepsy

3810.1

307.7

376

L01AX03

ATC

temozolomide; systemic

47.1

307.7

525

118

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

3431

N05CD08

ATC

midazolam; nasal, systemic

11.1

307.7

710

687

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

307.7

421

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

42.2

307.7

404

100

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

307.7

1326

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

9.9

298.1

348

365

H02AB02

ATC

dexamethasone; systemic

3.1

297.1

1465

5348

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

290.6

2115

9467

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

13.5

290.5

275

210

K90

ICPC

Stroke/cerebrovascular accident

5.6

281.6

555

1042

G41.2

ICD-10 Finland

Complex partial status epilepticus

121.0

281.5

143

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.5

281.2

732

1741

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.3

280.6

1175

3886

7803A

ICD-9 Finland

General symptoms, Convulsions

13.4

276.0

262

201

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

6.3

274.7

477

793

N03AE01

ATC

clonazepam; systemic

3.9

268.6

844

2307

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.3

264.7

298

297

R55

ICD-10 Finland

Syncope and collapse

2.9

258.2

1452

5670

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

111.6

257.7

132

Z2445

NOMESCO Finland

Psychologist

4.3

250.0

674

1644

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

7.9

250.0

349

458

N03AX22

ATC

perampanel; oral

2371.2

249.9

241

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

70.5

243.2

132

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

14.1

233.8

215

156

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

78.5

232.1

124

T90.5

ICD-10 Finland

Sequelae of intracranial injury

9.2

231.9

284

317

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

73.9

230.1

124

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1146.8

230.0

224

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.8

225.4

427

771

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

32.0

224.3

145

R41.0

ICD-10 Finland

Disorientation, unspecified

4.8

221.1

522

1144

R4150

NOMESCO Finland

Neuropsychological rehabilitation

12.4

220.3

219

181

H53.4

ICD-10 Finland

Visual field defects

5.9

215.7

397

697

N07

ICPC

Convulsion/seizure

34.2

213.0

135

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

13.6

211.6

198

148

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

1974.4

210.0

203

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

209.1

200

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

7.5

206.4

299

409

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

10.8

204.5

223

212

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

202.8

194

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.4

197.9

512

1206

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

195.6

1162

4629

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.3

192.7

234

258

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.8

191.7

304

459

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

24.0

189.3

135

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

189.2

181

N18

ICPC

Paralysis/weakness

5.7

189.2

362

659

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

187.1

179

TAB00

NOMESCO Finland

Lumbar puncture

3.7

184.2

621

1771

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.9

181.8

559

1496

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

181.1

1777

8886

130

Kela drug reimbursment

Malignant tumour

2.7

178.6

1069

4265

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

35.4

178.4

112

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.6

178.0

196

189

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.3

174.9

300

491

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.7

173.2

220

257

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

15.8

169.3

146

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

168.2

161

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

6.3

165.2

281

456

ZXC40

NOMESCO Finland

Use of ultrasound

10.7

159.1

174

166

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

158.5

3115

19832

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

157.1

768

2745

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

22.9

155.5

113

A28

ICPC

Limited function/disability NOS

2.1

153.5

1868

10086

S06.3

ICD-10 Finland

Focal brain injury

6.7

152.0

245

376

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

150.4

144

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.2

146.8

310

616

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.6

143.7

906

3693

N03AG04

ATC

vigabatrin; oral

+∞

143.1

137

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

8.7

142.5

182

214

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

13.3

141.5

134

102

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

141.3

2613

16201

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

56.9

140.2

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

7.7

140.0

198

263

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

1393.2

139.9

136

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

139.4

517

1565

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.6

138.2

264

479

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.9

136.8

213

315

G41.0

ICD-10 Finland

Grand mal status epilepticus

159.1

133.7

141

N03AF04

ATC

eslicarbazepine; oral

+∞

132.6

127

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

24.3

132.5

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

13.4

131.3

124

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.5

130.7

478

1433

WX892

NOMESCO Finland

Monitored bed care

2.5

129.5

856

3562

R4120

NOMESCO Finland

Occupational therapy

2.7

128.9

753

2949

N05AX08

ATC

risperidone; systemic

2.4

127.9

946

4147

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

1245.4

126.3

123

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

36.5

122.0

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

251.4

121.2

124

WX882

NOMESCO Finland

High dependency care

3.5

120.2

425

1246

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

49.6

119.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

118.3

801

3367

AAK00

NOMESCO Finland

Cranioplasty

38.2

116.9

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.9

113.3

155

198

S06.0

ICD-10 Finland

Concussion

2.1

112.8

1153

5773

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

62.4

111.7

R51.80

ICD-10 Finland

Headache

2.0

110.8

1532

8554

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

109.6

105

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

+∞

109.6

105

N74

ICPC

Malignant neoplasm nervous system

36.0

108.7

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

108.5

104

ZX050

NOMESCO Finland

Stereotactic radiotherapy

7.1

107.1

161

229

K91

ICPC

Cerebrovascular disease

5.3

106.0

218

423

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

103.4

313

825

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.4

103.2

204

382

SPAT1229

SPAT

Assessment of need for aid

2.4

103.1

777

3422

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

103.0

763

3335

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

102.3

4247

32088

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

102.2

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.6

101.9

145

194

AAF00

NOMESCO Finland

Ventriculostomy

9.2

100.7

122

134

Z51.5

ICD-10 Finland

Palliative care

2.2

100.3

913

4355

N28

ICPC

Limited function/disability (N)

4.5

100.3

251

574

W19

ICD-10 Finland

Unspecified fall

2.1

100.3

1033

5174

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.8

100.1

158

237

N06AB04

ATC

citalopram; systemic

1.8

99.1

1837

11216

R53

ICD-10 Finland

Malaise and fatigue

1.7

97.9

2381

15687

PA6AD

NOMESCO Finland

CT of neck arteries

3.0

97.3

439

1492

N03AX25

ATC

cenobamate; oral

+∞

97.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

97.0

1494

8608

SPAT1216

SPAT

Assessment of functional ability

1.9

96.5

1432

8152

F05.9

ICD-10 Finland

Delirium, unspecified

3.9

96.0

291

768

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.3

95.5

365

1123

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

54.3

94.8

L28

ICPC

Limited function/disability (L)

1.8

94.7

1759

10727

G41.8

ICD-10 Finland

Other status epilepticus

38.9

94.6

R42

ICD-10 Finland

Dizziness and giddiness

1.7

93.9

2113

13607

N05AH04

ATC

quetiapine; oral

1.8

93.9

1646

9865

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

196.0

93.5

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

10.4

93.0

103

100

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

15.1

92.1

N76

ICPC

Neoplasm nervous system unspecified

30.2

91.0

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

48.4

90.9

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

52.3

90.6

A04AA02

ATC

granisetron; systemic, transdermal

2.5

90.1

624

2641

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

6.0

88.9

159

271

3069, ,

Kela drug reimbursment

+∞

88.7

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

88.5

608

2563

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

88.2

1217

6749

1541, ,

Kela drug reimbursment

+∞

87.6

WX872

NOMESCO Finland

Intensive care

2.6

86.9

538

2159

R4130

NOMESCO Finland

Speech therapy

3.3

85.7

331

1025

N05BA04

ATC

oxazepam; oral

1.7

85.1

2291

15406

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

10.5

84.8

N29

ICPC

Neurological sympt/complt other

3.8

84.7

260

692

N02AA05

ATC

oxycodone; systemic

1.8

84.0

1654

10221

AA5PD

NOMESCO Finland

CT examination of brain pefusion

5.8

83.0

152

265

G91.0

ICD-10 Finland

Communicating hydrocephalus

8.7

82.9

105

122

R40.2

ICD-10 Finland

Coma, unspecified

6.2

82.7

141

229

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

82.4

983

5177

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

18.0

81.8

A06AD11

ATC

lactulose; oral

1.8

80.9

1357

7989

N19

ICPC

Speech disorder

4.1

80.3

226

565

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

80.3

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

80.3

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

80.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

80.2

1444

8683

XCK00

NOMESCO Finland

Perimetry

2.4

79.9

611

2700

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

27.1

79.1

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

78.8

1363

8096

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

78.4

493

1991

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

78.4

579

2519

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

77.7

1876

12224

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

77.3

1199

6884

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

77.2

431

1641

WX730

NOMESCO Finland

Conventional respirator

4.3

76.9

204

488

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.9

76.7

226

584

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

24.7

76.4

WF002

NOMESCO Finland

Radical radiotherapy

2.4

76.4

566

2466

S01.0

ICD-10 Finland

Open wound of scalp

2.1

75.9

791

3960

Z2446

NOMESCO Finland

Social worker

2.2

75.6

666

3123

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

75.5

1034

5701

S06.2

ICD-10 Finland

Diffuse brain injury

5.4

75.0

150

284

SPAT1234

SPAT

Support of social functional capacity

2.4

74.9

533

2280

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.9

74.6

165

341

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

74.0

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

9.3

73.6

PA2AD

NOMESCO Finland

CT angiography of brain

5.7

73.3

138

247

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

72.3

214

555

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

10.2

72.2

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

7.8

72.0

100

130

A86

ICD-10 Finland

Unspecified viral encephalitis

8.3

71.7

114

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

15.1

71.6

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.6

70.0

104

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

181.3

69.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

69.1

474

1993

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

68.1

1198

7126

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

68.1

654

3171

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

31.6

67.6

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

66.1

625

3010

N05AH03

ATC

olanzapine; systemic

2.2

66.0

587

2760

F80.1

ICD-10 Finland

Expressive language disorder

4.7

65.8

152

326

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.6

65.6

AAA10

NOMESCO Finland

Biopsy through craniotomy

23.6

65.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

65.4

1923

13086

H47.2

ICD-10 Finland

Optic atrophy

8.2

64.4

104

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.9

64.3

143

297

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.8

64.0

145

306

SPAT1254

SPAT

Administration of medicine

1.7

63.9

1342

8381

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

17.4

63.5

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

10.9

63.4

R1260

NOMESCO Finland

Evaluation of communicative skills

3.8

63.1

196

526

R56.0

ICD-10 Finland

Febrile convulsions

7.9

62.8

110

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

61.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

61.1

1014

5918

P20

ICPC

Memory disturbance

1.7

60.5

1201

7378

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

60.5

N05CF01

ATC

zopiclone; oral

1.5

59.4

2617

19383

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

59.3

319

1191

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

8.3

58.1

ZXD05

NOMESCO Finland

Urgent procedure

1.5

58.0

2504

18450

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

58.0

1540

10192

SPAT1301

SPAT

No procedures

1.5

57.9

2610

19399

ZXY02

NOMESCO Finland

Neuropsychologist

6.7

57.9

136

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.7

57.4

183

500

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

57.3

716

3814

C03CA01

ATC

furosemide; systemic

1.5

57.1

2519

18632

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

13.7

57.0

ZXM40

NOMESCO Finland

Use of fluorescent substance

16.9

56.5

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

56.2

446

1998

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.3

56.1

144

336

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

89.2

55.9

N99

ICPC

Neurological disease other

4.0

55.1

159

405

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

54.2

M03BX01

ATC

baclofen; systemic

3.3

54.1

205

627

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

53.9

1643

11211

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.6

53.6

129

286

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.9

53.5

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

53.4

338

1368

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.8

52.3

164

443

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

8.6

52.0

2152

FHL

Extraction, big brain

14.9

51.9

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

14.9

51.9

N06AB10

ATC

escitalopram; oral

1.6

51.8

1655

11400

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

11.3

51.7

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

+∞

51.1

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

19.1

50.9

2161

FHL

Neck ligation, big brain

9.3

50.9

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

7.3

50.7

102

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

11.6

50.6

N03AG06

ATC

tiagabine; oral

500.6

50.4

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

256.8

50.1

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

80.6

49.9

N06AX11

ATC

mirtazapine; oral

1.4

49.7

2750

21123

R41.3

ICD-10 Finland

Other amnesia

2.6

49.3

291

1138

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

14.7

49.3

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.5

48.9

310

1255

OAB43, ,

SPAT

0.6

48.9

1258

18468

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

20.6

48.7

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

15.6

48.5

S06.4

ICD-10 Finland

Epidural haemorrhage

12.8

48.5

G81.1

ICD-10 Finland

Spastic hemiplegia

13.7

48.4

3453A

ICD-9 Finland

Epilepsy, Grand mal status

480.3

48.4

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

15.8

47.7

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.4

47.5

331

1400

N05AA02

ATC

levomepromazine; systemic

2.4

47.3

347

1502

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

47.0

594

3170

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

46.9

Z3231

NOMESCO Finland

Registered nurse

1.4

46.6

2254

16846

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

9.1

45.9

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

45.9

190

614

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

45.4

1862

13472

B01AA03

ATC

warfarin; systemic

1.5

45.3

1545

10761

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

45.3

1288

8618

B01AC04

ATC

clopidogrel; oral

1.6

44.8

1330

8982

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

157.4

44.8

N05CD07

ATC

temazepam; oral

1.7

44.8

901

5529

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.7

44.7

141

383

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

44.7

248

941

N02BE01

ATC

paracetamol; systemic, rectal

1.5

44.6

7617

70301

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

15.9

44.3

N03AX12

ATC

[U] gabapentin; oral

1.6

44.3

1256

8395

R11

ICD-10 Finland

Nausea and vomiting

1.8

44.1

772

4557

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

43.9

435

2129

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

10.5

43.7

R50.9

ICD-10 Finland

Fever, unspecified

1.6

43.6

1323

8976

G72.8

ICD-10 Finland

Other specified myopathies

3.3

43.0

164

504

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

42.8

682

3914

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

42.8

1116

7307

N05AD01

ATC

haloperidol; systemic

2.5

42.6

285

1184

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

42.3

383

1810

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

215.9

41.9

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

41.7

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.5

41.6

103

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

41.4

522

2782

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

41.2

486

2531

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

5.9

41.0

124

P85

ICPC

Mental retardation

8.2

41.0

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

210.9

40.9

G40.8

ICD-10 Finland

Other epilepsy

+∞

40.6

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

40.5

2040

15297

A04AA01

ATC

ondansetron; systemic, rectal

1.8

40.5

672

3903

F83

ICD-10 Finland

Mixed specific developmental disorders

4.7

40.2

196

D32.03

ICD-10 Finland

Benign meningioma in ventricles

13.1

39.9

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

7.6

39.8

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

10.0

39.7

G40.59

ICD-10 Finland

Other special epileptic syndromes

+∞

39.6

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

39.5

709

4212

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

39.1

105

254

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.8

38.8

191

681

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

38.6

751

4559

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

38.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

38.4

208

780

I61

ICD-10 Finland

Intracerebral haemorrhage

12.3

38.4

H02AB09

ATC

hydrocortisone; systemic

2.5

38.3

239

961

I63.8

ICD-10 Finland

Other cerebral infarction

3.9

38.2

111

285

A02BC02

ATC

pantoprazole; systemic

1.3

38.0

5546

48959

OAA67, ,

SPAT

0.6

37.9

537

9230

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

37.7

353

1689

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

37.5

2144

16402

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

37.5

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.0

37.5

107

271

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.6

37.4

214

825

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

37.3

2748

21909

R4110

NOMESCO Finland

Physiotherapy

1.4

37.3

2181

16749

SPAT1240

SPAT

Therapeutic discussion

1.7

37.0

804

5025

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

9.0

36.8

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

36.7

1246

17442

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

36.5

521

2888

RS222, ,

NOMESCO Finland

3.4

36.4

129

379

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

6.7

36.4

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

54.0

36.3

WYA20

NOMESCO Finland

Home visit

2.8

36.3

186

678

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.0

36.2

108

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

7.9

36.1

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

60.2

36.1

A04

ICPC

Weakness/tiredness general

1.5

36.0

1327

9349

B01AC07

ATC

dipyridamole; systemic

2.1

35.9

367

1817

Z3226

NOMESCO Finland

Physiotherapist

1.5

35.8

1412

10085

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

185.7

35.8

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

185.7

35.8

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

35.5

303

1398

N03AX16

ATC

[U] pregabalin

1.4

35.5

1724

12800

H53.2

ICD-10 Finland

Diplopia

2.3

35.5

283

1270

34519

ICD-8 Finland

Epilepsy, Generalisata convulsiva NUD

+∞

35.4

R5110, ,

SPAT

1.7

35.4

681

4120

SPAT1053

SPAT

Memory test

1.5

35.3

1060

7150

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

35.3

2497

19746

G83.8

ICD-10 Finland

Other specified paralytic syndromes

12.6

34.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

34.6

1505

10944

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

34.4

374

1892

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

11.7

34.2

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

34.2

342

1679

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.4

33.9

124

372

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

33.8

274

1238

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

33.5

324

1571

F03

ICD-10 Finland

Unspecified dementia

2.0

33.3

354

1777

Y86

ICD-10 Finland

Sequelae of other accidents

5.9

33.3

100

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

63.5

33.0

-, ,

ICD-10 Finland

2.6

33.0

198

782

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.0

33.0

148

502

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

328.3

32.9

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

32.8

184

703

G93.0

ICD-10 Finland

Cerebral cysts

5.7

32.7

105

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

32.7

2987

24480

SPAT1252

SPAT

Overall medication plan or its review

1.8

32.5

521

2993

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

32.3

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

5.6

32.3

110

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

13.0

32.2

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.2

32.1

208

JN4AD

NOMESCO Finland

Body CT examination

1.6

32.0

900

5975

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

11.0

32.0

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

6.7

31.8

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

31.8

331

1650

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

31.8

365

1884

F05.8

ICD-10 Finland

Other delirium

4.0

31.5

224

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

9.5

31.5

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

31.3

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.4

31.1

223

956

GBB00

NOMESCO Finland

Tracheostomy

3.4

31.1

111

328

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.1

31.0

285

1355

G41.1

ICD-10 Finland

Petit mal status epilepticus

42.3

30.8

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.6

30.4

102

R25.2

ICD-10 Finland

Cramp and spasm

2.4

30.4

215

917

Z75.5

ICD-10 Finland

Holiday relief care

4.0

30.3

213

G45.4

ICD-10 Finland

Transient global amnesia

2.5

30.3

192

779

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.2

30.1

116

360

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

29.7

1025

7106

F44.5

ICD-10 Finland

Dissociative convulsions

82.9

29.7

B01AB05

ATC

enoxaparin; parenteral

1.3

29.2

2330

18660

3450A

ICD-9 Finland

Epilepsy, Generalised nonconvulsive epilepsy

+∞

29.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

29.0

575

3503

ZXD35

NOMESCO Finland

Usual procedure

2.1

28.9

261

1233

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.5

28.8

157

S22.3

ICD-10 Finland

Fracture of rib

1.7

28.8

576

3517

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.4

28.6

196

824

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.0

28.5

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.2

28.3

176

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.5

28.2

280

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.7

28.2

148

547

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

28.1

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

28.1

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

28.1

135

476

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

28.0

888

6045

A29

ICPC

General symptom/complaint other

1.5

27.9

1062

7504

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

27.9

367

1982

R40.0

ICD-10 Finland

Somnolence

5.6

27.8

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

145.4

27.6

ZX095

NOMESCO Finland

Combined chemoradiotherapy

4.2

27.6

171

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

6.5

27.2

RS221, ,

NOMESCO Finland

2.8

26.9

133

476

Q85.1

ICD-10 Finland

Tuberous sclerosis

62.2

26.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

26.8

278

1383

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.6

26.7

138

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.5

26.7

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.1

26.5

109

352

C08CA01

ATC

amlodipine; oral

1.3

26.3

2886

24065

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

25.8

26.1

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.8

26.0

130

469

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

25.7

367

2035

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

25.6

868

5987

ZY010

NOMESCO Finland

Hospital outpatient

1.8

25.6

406

2324

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.4

25.6

269

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

4.0

25.5

177

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.2

25.4

101

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

10.4

25.3

S02.11

ICD-10 Finland

Fracture of base of skull, open

5.9

25.2

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.1

25.2

166

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.3

25.1

292

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.7

25.1

220

AA9CW, ,

NOMESCO Finland

8.9

25.0

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

8.9

25.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

24.9

1453

11059

E87.6

ICD-10 Finland

Hypokalaemia

2.0

24.8

267

1348

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

70.0

24.8

Z50.5

ICD-10 Finland

Speech therapy

2.7

24.7

136

516

N05AB03

ATC

perphenazine; systemic, rectal

2.0

24.6

255

1269

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

24.5

206

946

N05AX12

ATC

aripiprazole; systemic

1.9

24.3

299

1581

F10.24

ICD-10 Finland

Alcohol depence active use

2.7

24.2

131

492

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

48.4

24.2

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.6

24.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

24.2

1061

7688

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.4

24.1

250

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.3

24.0

190

851

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

56.1

24.0

C02AC05

ATC

moxonidine; oral

1.8

23.9

344

1911

N06AX16

ATC

venlafaxine; oral

1.4

23.9

1003

7211

H03AA01

ATC

levothyroxine sodium; systemic

1.3

23.8

1603

12466

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.4

23.8

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

23.7

2286

18691

M01AH05

ATC

etoricoxib; oral

0.8

23.7

3750

42571

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

6.9

23.7

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

23.7

336

1860

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

23.6

401

2340

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.3

23.5

JN4BD

NOMESCO Finland

Extensive body CT

1.5

23.4

732

4966

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

23.3

153

632

N30.0

ICD-10 Finland

Acute cystitis

1.4

23.3

1243

9315

N06AX22

ATC

agomelatine; oral

2.3

23.3

183

818

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.3

23.2

261

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

9.7

23.2

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

23.2

477

2934

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.4

23.0

238

OAB48, ,

SPAT

0.6

23.0

600

8953

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

20.1

22.9

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.4

22.9

163

698

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

5.2

22.9

U04

ICPC

Incontinence urine

1.7

22.9

435

2620

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.3

22.8

259

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.2

22.7

D21

ICPC

Swallowing problem

2.5

22.6

137

545

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

120.3

22.6

N03AA02

ATC

phenobarbital; systemic

18.9

22.5

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.8

22.4

112

404

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.3

22.4

247

R4120, ,

SPAT

2.7

22.3

122

461

Z00.0

ICD-10 Finland

General medical examination

1.3

22.3

1463

11319

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

22.3

2157

17622

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.1

22.2

151

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

22.0

573

3730

N06AB06

ATC

sertraline; oral

1.5

22.0

819

5750

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

21.9

5801

53178

N03AD01

ATC

ethosuximide; oral

+∞

21.9

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

21.9

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

21.9

N07BB01

ATC

disulfiram; oral

1.8

21.7

302

1661

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.3

21.7

247

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

21.7

374

2193

AAK80

NOMESCO Finland

Partial excision of skull cap

18.4

21.7

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

21.6

417

2522

C71

ICD-10 Finland

Malignant neoplasm of brain

115.3

21.6

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

21.5

552

3583

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

4.0

21.4

155

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

21.4

279

1504

N06DA03

ATC

rivastigmine; oral, transdermal

1.8

21.4

329

1867

OAA80, ,

SPAT

0.6

21.3

298

5177

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

17.4

21.3

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.4

21.2

122

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

7.5

21.2

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

7.2

21.2

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.5

21.1

128

510

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.3

21.0

127

N05AF03

ATC

chlorprothixene; systemic

2.2

21.0

182

847

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

4.8

21.0

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

20.8

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

20.8

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

24.2

20.8

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

20.8

954

6960

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

3.6

20.8

186

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

20.7

504

3229

S18

ICPC

Laceration/cut

1.2

20.7

3642

31856

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.3

20.7

152

661

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

20.7

155

680

WZC30

NOMESCO Finland

Teaching

1.4

20.6

1213

9222

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.6

20.6

192

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

20.5

144

614

N05AD03

ATC

melperone; systemic

2.8

20.5

102

368

SPAT1263

SPAT

Sampling

1.2

20.5

3169

27326

F07.2

ICD-10 Finland

Postconcussional syndrome

7.8

20.4

N80

ICPC

Head injury other

2.1

20.4

186

884

J01EA01

ATC

trimethoprim; systemic

1.3

20.2

1784

14371

WX704

NOMESCO Finland

Intubation

1.5

20.2

596

3988

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

32.6

20.1

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

32.6

20.1

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

20.1

379

2277

AA1AA

NOMESCO Finland

Head X-ray examination

3.2

20.0

250

SPAT1153

SPAT

Removal of sutures

1.3

19.9

2248

18675

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

57.6

19.9

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

4.3

19.8

116

C07AA05

ATC

propranolol; systemic

1.3

19.8

1390

10845

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

19.8

493

3176

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

19.8

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

6.1

19.8

SPAT1172

SPAT

Guidance concerning hydration

2.1

19.7

176

830

C10AA01

ATC

simvastatin; oral

1.2

19.6

2978

25590

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

16.4

19.6

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

19.6

226

1171

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

40.1

19.5

J01DB01

ATC

cefalexin; oral

1.3

19.4

6836

64171

SPAT1260

SPAT

Consultation of another employee

1.3

19.4

1255

9674

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.9

19.4

144

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

19.4

109

419

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

19.2

316

1830

WF004

NOMESCO Finland

Palliative radiotherapy

2.2

19.2

165

767

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.1

19.1

172

813

F06.32

ICD-10 Finland

Organic depression

5.9

19.1

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

16.7

19.1

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

19.0

947

7005

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

19.0

820

11148

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.7

18.9

G44.2

ICD-10 Finland

Tension-type headache

1.4

18.9

946

7000

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

55.1

18.9

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

6.2

18.9

F06.0

ICD-10 Finland

Organic hallucinosis

5.8

18.8

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

18.7

I68.0*E85.9

ICD-10 Finland

Cerebral amyloid angiopathy

8.1

18.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

3.6

18.7

171

N05CD02

ATC

nitrazepam; oral

2.4

18.7

122

504

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

7.7

18.7

RL140, ,

NOMESCO Finland

5.9

18.7

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

17.1

18.6

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

18.6

695

4879

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

7.3

18.6

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.0

18.6

282

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

20.8

18.6

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

190.3

18.5

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

38.4

18.5

SPAT1210

SPAT

Application of cast or individual aid

1.8

18.5

285

1620

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.0

18.4

268

N06DX01

ATC

memantine; oral

1.5

18.4

541

3619

G93.6

ICD-10 Finland

Cerebral oedema

30.1

18.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

18.3

2895

24944

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

18.3

646

4488

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

18.2

724

5143

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

18.1

236

1274

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

18.1

287

1645

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

18.0

103

399

RS122, ,

NOMESCO Finland

5.0

18.0

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

18.0

405

2547

R5130, ,

SPAT

4.3

18.0

108

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

17.9

747

5351

N05BA02

ATC

chlordiazepoxide; systemic

2.1

17.9

163

775

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.1

17.9

167

802

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

17.8

447

2886

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

17.8

119

497

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

18.0

17.7

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

17.7

34509

ICD-8 Finland

Epilepsy, Absentia epileptica NUD

+∞

17.7

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

+∞

17.7

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

17.7

AA11X, ,

NOMESCO Finland

+∞

17.7

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

17.7

RS340, ,

NOMESCO Finland

5.2

17.6

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

17.6

382

2381

P29

ICPC

Psychological sympt/compl other

1.5

17.6

552

3742

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

17.6

512

3417

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

95.2

17.5

AAA40

NOMESCO Finland

Insertion of intracerebral electrodes

180.3

17.5

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.6

17.4

160

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

17.4

455

2964

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

17.4

431

2773

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.8

17.4

259

1457

SPAT1101

SPAT

Orthostatic test

1.7

17.4

304

1792

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

7.0

17.3

N05AH02

ATC

clozapine; systemic

2.3

17.3

129

565

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

18.6

17.3

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

3.0

17.2

241

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.5

17.2

171

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

17.2

359

2217

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.9

17.2

268

R60.0

ICD-10 Finland

Localized oedema

1.4

17.2

913

6820

W06

ICD-10 Finland

Fall involving bed

3.0

17.2

247

RS230, ,

NOMESCO Finland

3.7

17.1

148

RS121, ,

NOMESCO Finland

3.4

17.0

182

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

16.9

208

1102

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

16.9

412

2643

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.9

16.9

260

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.1

16.9

161

780

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

21.9

16.8

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

16.7

1809

14907

G40.33

ICD-10 Finland

Juvenile absence epilepsy

+∞

16.7

G40.35

ICD-10 Finland

Juvenile absence epilepsy

+∞

16.7

A07

ICPC

Coma

3.8

16.6

128

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

35.1

16.6

5AB01, ,

NOMESCO Finland

6.7

16.5

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

16.3

16.5

P72

ICPC

Schizophrenia

2.2

16.5

137

629

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

16.4

864

6442

XX3XW, ,

NOMESCO Finland

3.5

16.4

162

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

20.0

16.4

C07AB07

ATC

bisoprolol; oral

1.2

16.3

3605

32015

EBA00

NOMESCO Finland

Extraction of tooth

1.2

16.2

2782

24095

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

16.2

156

758

S72.0

ICD-10 Finland

Fracture of neck of femur

1.7

16.2

283

1668

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

16.2

1699

13945

SPAT1167

SPAT

Insertion of urinary catheter

1.8

16.1

229

1270

K59.0

ICD-10 Finland

Constipation

1.6

16.1

413

2680

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

6.8

16.1

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

30.1

16.1

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.0

16.1

109

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

4.5

16.1

N04AA02

ATC

biperiden; systemic

2.2

16.0

128

578

N75

ICPC

Benign neoplasm nervous system

16.7

16.0

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.5

16.0

435

2860

N27

ICPC

Fear of neurological disease other

2.2

16.0

135

624

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

15.9

284

1685

S02.10

ICD-10 Finland

Fracture of base of skull, closed

4.1

15.8

106

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.6

15.8

332

J01CA08

ATC

pivmecillinam; oral

1.2

15.7

2665

23037

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

60.1

15.7

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

60.1

15.7

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.1

15.7

140

661

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

15.7

206

1115

X58

ICD-10 Finland

Exposure to other specified factors

1.3

15.7

1083

8411

XX9WW, ,

NOMESCO Finland

+∞

15.6

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

12.9

15.6

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

15.6

792

5868

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

15.6

379

2430

R33

ICD-10 Finland

Retention of urine

1.5

15.5

576

4037

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

15.5

117

516

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

19.2

15.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

15.5

308

1879

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

15.5

183

957

N05BA12

ATC

alprazolam; oral

1.4

15.5

651

4670

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

160.2

15.5

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.0

15.5

166

840

XF404

NOMESCO Finland

Ambulatory ECG

1.4

15.4

599

4234

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

15.4

394

2556

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

5.4

15.4

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

5.4

15.4

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.7

15.3

308

N06AX03

ATC

mianserin; oral

1.7

15.3

311

1908

GD1AA, ,

SPAT

0.7

15.2

665

9046

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

15.2

293

1774

R56

ICD-10 Finland

Convulsions, not elsewhere classified

28.6

15.2

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

3.9

15.1

110

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

15.0

187

996

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

15.0

247

1433

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1.8

15.0

241

1389

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

14.9

617

4413

SPAT1104

SPAT

Monitoring of emergency patient

1.5

14.9

444

2979

E86

ICD-10 Finland

Volume depletion

1.9

14.9

181

957

G30.8

ICD-10 Finland

Other Alzheimer disease

1.9

14.8

178

936

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

15.0

14.8

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.7

14.8

125

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

14.8

490

3360

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

31.7

14.8

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

56.7

14.8

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.6

14.7

130

SPAT1310

SPAT

Counselling related to known health issue

1.2

14.7

2258

19302

C09AA05

ATC

ramipril; oral

1.3

14.7

1732

14390

R13

ICD-10 Finland

Dysphagia

1.5

14.7

486

3332

2151

FHL

Resection, big brain

25.0

14.7

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

3.4

14.6

150

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.4

14.6

399

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

14.6

3457B

ICD-9 Finland

Epilepsy, Epilepsia partialis continua[EPILEPSIA PARTIALIS CONTINUA]

+∞

14.6

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

11.8

14.5

P03

ICPC

Feeling depressed

1.4

14.5

702

5159

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

14.5

129

609

ZXA05

NOMESCO Finland

Left side

1.3

14.5

1670

13835

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.1

14.5

139

676

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.4

14.5

151

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.7

14.4

243

1418

RS142, ,

NOMESCO Finland

4.8

14.4

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

5.8

14.4

G43.3

ICD-10 Finland

Complicated migraine

2.2

14.4

118

539

A46

ICD-10 Finland

Erysipelas

1.3

14.4

1049

8203

F40.2

ICD-10 Finland

Specific (isolated) phobias

3.0

14.4

202

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

14.4

777

5816

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.9

14.3

191

1040

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

14.3

3129

27664

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

27.2

14.2

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.8

14.2

194

1064

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

14.2

2698

23533

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.0

14.2

154

783

A10AB05

ATC

insulin aspart; parenteral

1.4

14.1

543

3831

SPAT1251

SPAT

Organisation of medication

1.7

14.1

239

1398

RT150, ,

NOMESCO Finland

3.8

14.1

111

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.9

14.1

162

841

ZXA00

NOMESCO Finland

Right side

1.2

14.1

1794

15027

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1.9

14.1

167

876

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.4

14.0

382

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

14.0

455

3107

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

14.4

14.0

RS211, ,

NOMESCO Finland

3.8

14.0

107

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

14.0

361

2348

H50.31

ICD-10 Finland

Intermittent exotropia

2.8

14.0

249

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

10.9

14.0

P99

ICPC

Psychological disorders other

1.8

13.9

210

1188

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.6

13.9

126

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

5.2

13.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

13.8

655

4796

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

13.8

278

1702

N06AG02

ATC

moclobemide; oral

1.7

13.8

270

1643

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

13.8

444

3029

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

23.8

13.8

9070A

ICD-9 Finland

Late effects of injuries to the nervous system, Late effect of intracranial injury without mention of skull fracture

11.4

13.7

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.7

13.7

280

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.4

13.7

387

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

5.7

13.6

OAB95, ,

SPAT

0.6

13.6

247

4015

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019977) pH of Arterial blood

2129

9302

2.68

309.40

8.2

7.9

7.42

0.05

1363

5005

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1077

2769

4.28

307.65

2.4

2.3

339.15

598.27

ug/l

2.14

1038

2628

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

448

403

11.64

307.65

1.8

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

246

117

21.57

307.65

2.4

2.0

20.94

15.13

umol/l

5.27

246

117

(3009466) Valproate [Moles/volume] in Serum or Plasma

1505

702

25.49

307.65

3.8

6.2

366.39

359.05

umol/l

0.60

1334

602

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

510

707

7.58

307.65

1.8

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1314

307.02

307.65

2.7

2.3

55.01

36.86

umol/l

3.03

1175

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

251

92.13

307.65

3.6

3.2

42.13

38.00

umol/l

0.31

231

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

799

1721

4.99

307.65

1.4

1.5

3.84

3.72

mmol/l

1.96

756

1625

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

869

1945

4.83

307.65

1.5

552.80

527.61

mg/l

0.52

835

1860

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2773

12277

2.81

307.65

2.3

28.78

29.81

12.57

2696

11941

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5080

23825

3.57

307.65

3.6

2.2

218.53

213.90

u/l

0.09

4948

22533

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

710

105.39

307.65

3.5

2.1

30.04

26.76

umol/l

1.06

552

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5482

35282

2.40

307.65

8.4

7.0

1.20

1.21

mmol/l

37.31

5248

32710

(3027801) Oxygen [Partial pressure] in Arterial blood

2123

9317

2.67

305.35

8.1

7.9

14.08

12.38

kpa

27.23

2053

8946

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2123

9319

2.67

305.20

8.1

7.9

5.03

5.09

kpa

2.02

2053

8948

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5804

39439

2.31

304.73

9.2

7.6

1.20

1.21

mmol/l

33.28

5201

34201

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

746

1695

4.70

303.97

1.6

29.75

24.31

e6/l

0.27

575

1226

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

751

1717

4.68

303.66

1.7

4542.41

3094.31

e6/l

0.16

612

1329

(3003396) Base excess in Arterial blood by calculation

2103

9243

2.66

301.10

8.2

7.9

1.03

0.88

mmol/l

1.03

1703

7568

(3013826) Glucose [Moles/volume] in Serum or Plasma

6281

46339

2.15

237.76

7.9

5.2

6.61

6.70

mmol/l

2.68

6105

43819

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

128

68.29

234.71

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

375

577

6.73

232.54

1.5

1.2

2.24

2.07

mmol/l

1.24

349

535

(3023183) Ammonium ion [Moles/volume] in Plasma

647

1704

4.01

215.82

2.9

31.46

34.06

umol/l

1.74

582

1548

(3032080) INR in Blood by Coagulation assay

5133

36123

1.97

208.51

16.9

15.7

1.25

1.27

inr

3.05

4424

30199

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

294

400

7.56

203.87

1.2

1.1

—

(3016502) Oxygen saturation in Arterial blood

1754

8361

2.36

202.39

8.9

8.2

96.26

95.57

5.08

1706

8062

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1655

7766

2.38

197.50

9.2

8.7

123.41

121.35

g/l

3.97

1626

7584

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

272

357

7.82

194.56

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

264

351

7.71

186.72

1.7

1.4

—

(3023368) Bacteria identified in Blood by Culture

3501

22250

1.93

186.14

4.7

4.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4276

29336

1.86

176.60

5.2

3.8

44.29

79.85

ng/l

0.97

3361

20284

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2338

13417

2.00

163.58

4.0

3.8

0.81

0.82

mmol/l

0.60

2204

12657

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2326

13520

1.97

155.67

2.1

1.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1114

4834

2.49

155.48

8.1

10.1

24.27

24.23

mmol/l

0.16

1100

4727

(3018418) pH of Serum or Plasma

3523

23466

1.82

153.71

4.5

4.3

7.40

0.94

2655

16740

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1185

5326

2.41

152.96

8.9

10.0

1.35

1.32

0.45

1178

5292

(3003181) Sodium [Moles/volume] in Urine

500

1413

3.69

149.86

1.5

70.67

63.00

mmol/l

3.03

416

1141

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1112

4901

2.45

149.73

9.8

6.6

24.62

24.46

mmol/l

0.74

1074

4683

(3020191) Ethanol [Moles/volume] in Serum or Plasma

317

633

5.15

149.32

1.8

1.4

0.67

1.31

promille

10.49

259

504

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1261

5902

2.32

148.07

7.9

9.3

24.39

24.81

mmol/l

4.65

1250

5867

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

236

8.02

136.79

1.3

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1471

7560

2.13

136.27

2.5

2.3

372.66

376.44

nmol/l

0.29

1361

7039

(3014111) Lactate [Moles/volume] in Serum or Plasma

1445

7459

2.11

131.99

7.3

8.1

1.42

1.33

mmol/l

2.40

1418

7295

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1788

10071

1.96

127.84

2.0

1.8

—

(3020891) Body temperature

875

3708

2.50

127.33

5.7

4.5

36.91

°c

0.24

867

3667

(3024561) Albumin [Mass/volume] in Serum or Plasma

4713

35384

1.69

125.94

5.9

5.3

35.07

35.69

g/l

10.48

4459

33174

(3023410) Appearance of Cerebral spinal fluid

327

800

4.20

119.75

1.7

2.1

—

(3026008) Bacteria identified in Urine by Culture

3375

23447

1.70

118.62

3.7

3.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

662

2538

2.73

117.86

4.9

3.9

1.52

1.39

mmol/l

1.63

655

2492

(3000991) Gas panel - Venous blood

1414

7568

2.03

115.86

8.2

9.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1659

9461

1.92

112.81

2.0

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1562

8778

1.94

110.79

4.1

4.5

5.91

5.81

kpa

3.58

1525

8555

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5210

40943

1.64

109.96

8.9

6.7

10.16

12.07

umol/l

21.96

4972

39024

(3033658) Prothrombin time (PT) actual/Normal

2959

20278

1.68

106.73

4.9

4.4

88.84

88.41

0.42

2889

19847

(3024354) Oxygen [Partial pressure] in Venous blood

1361

7389

1.99

106.39

3.8

4.0

4.61

4.60

kpa

0.08

1326

7185

(3002032) Base excess in Venous blood by calculation

1510

8579

1.91

102.93

4.1

4.5

1.94

1.69

mmol/l

2.06

1339

7452

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

149

213

7.09

98.70

1.2

1.1

—

(3012544) pH of Venous blood

1533

8926

1.86

96.23

4.1

4.5

7.38

0.05

932

5218

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1496

8666

1.87

95.36

10.1

7.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

143

205

7.07

94.49

1.2

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

863

4139

2.20

93.26

1.6

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

144

211

6.92

93.25

1.2

1.1

—

(3036489) Thrombin time

684

3059

2.34

87.23

2.2

2.6

21.03

21.20

0.27

626

2724

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

274

743

3.77

86.89

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

11.88

84.89

1.2

1.0

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

179

355

5.12

84.88

1.7

1.2

48.97

72.36

2.82

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

10.31

84.37

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

197

6.78

84.04

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3563

26697

1.55

83.25

4.6

3.5

2.34

2.35

mmol/l

12.92

3272

24330

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1744

10983

1.73

82.64

5.6

6.7

1.03

1.06

mmol/l

4.88

1630

10271

(3031040) Bacteria [#/volume] in Urine by Automated count

6048

51018

1.55

80.51

5.9

4.7

3626.87

1764.80

e6/l

0.90

106

717

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

163

317

5.22

79.04

1.2

1.1

570.93

344.00

ng/l

0.20

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

238

630

3.85

78.12

1.2

1.1

41.72

41.71

mg/l

0.00

206

526

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

850

4349

2.05

77.00

3.3

3.4

1.29

1.24

0.73

844

4324

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

232

611

3.87

76.70

1.1

270.63

265.44

mg/l

0.13

212

540

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

804

4053

2.08

75.77

4.5

4.3

50.66

47.43

3.45

793

3988

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3759

28908

1.51

75.54

3.9

3.6

—

2.10

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1148

6578

1.85

74.30

2.7

2.3

5.75

7.50

ug/l

3.53

991

5754

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

90.83

73.00

1.1

1.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1983

13289

1.63

72.92

1.9

1.8

1202.26

1159.12

nmol/l

1.37

1576

10105

(3020779) Urea [Moles/volume] in Serum or Plasma

1295

7759

1.78

72.17

6.6

8.0

7.97

9.87

mmol/l

20.58

1237

7442

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

214

566

3.85

70.33

1.1

—

(3008295) Osmolality of Serum or Plasma

277

871

3.25

69.90

1.4

1.5

277.94

280.02

mosm/kgh2o

0.64

201

663

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2700

19621

1.53

69.31

2.6

2.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

874

4697

1.95

68.55

11.1

10.3

16.35

16.01

3.32

841

4526

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

117

191

6.19

68.33

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.95

68.32

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

9.71

67.98

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

926

5146

1.89

65.52

3.6

3.7

129.70

129.40

g/l

0.16

909

5004

(3013650) Neutrophils [#/volume] in Blood by Automated count

5393

45409

1.46

64.19

12.3

9.8

4.07

4.14

e9/l

1.26

4737

39193

(3026782) Osmolality of Urine

2197

15592

1.54

61.50

3.1

534.21

537.40

mosm/kgh2o

0.28

1951

13690

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2156

15245

1.54

61.35

3.3

3.0

2.44

2.45

mmol/l

6.66

1942

13623

(3027273) Bicarbonate [Moles/volume] in Venous blood

707

3666

2.01

61.22

3.8

3.7

25.30

25.20

mmol/l

0.34

685

3540

(1761868) Lipid panel - Serum or Plasma

2175

29447

0.66

60.96

3.1

—

(3006315) Basophils [#/volume] in Blood

4917

40976

1.44

59.81

7.5

6.6

0.04

e9/l

11.45

4263

35071

(4035726) Immunohistochemistry procedure

1106

6660

1.75

59.77

1.4

—

(3001604) Monocytes [#/volume] in Blood

4903

40860

1.43

59.49

7.5

6.6

0.59

e9/l

0.13

4254

34953

(3019198) Lymphocytes [#/volume] in Blood

4998

41826

1.43

59.08

7.6

6.6

1.81

1.92

e9/l

2.65

4411

36690

(4027681) Cerebrospinal fluid IgG ratio and IgG index

178

468

3.86

59.02

1.3

1.2

0.55

0.63

ratio

1.81

108

277

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6667

58919

1.49

58.92

10.8

8.3

82.25

80.35

u/l

1.97

6392

56012

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

157

6.30

58.33

1.1

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

892

5077

1.84

58.21

4.3

4.4

1.73

1.69

mmol/l

0.13

659

3724

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

866

4907

1.84

57.29

1.8

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

995

5887

1.77

57.01

4.3

4.4

5.19

5.13

kpa

1.69

937

5631

(3013115) Eosinophils [#/volume] in Blood

5019

42183

1.42

56.95

7.9

6.8

0.17

0.20

e9/l

17.75

4407

36725

(3009343) pH of Capillary blood

969

5731

1.77

55.52

4.3

4.4

7.41

7.42

2.23

831

4723

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

924

5407

1.79

54.86

3.8

4.8

24.26

24.07

mmol/l

1.16

914

5349

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

249

849

2.99

54.74

1.5

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4429

36664

1.41

53.25

3.1

2.9

—

estimate

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

669

3613

1.92

51.20

8.1

4.9

1.64

1.62

0.16

631

3407

(3016038) Potassium [Moles/volume] in Urine

183

548

3.39

50.00

1.4

33.84

35.95

mmol/l

0.59

159

488

(3007930) Methemoglobin/Hemoglobin.total in Blood

626

3334

1.94

49.91

8.5

5.1

0.91

0.88

1.20

589

3141

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3169

25028

1.41

48.67

3.3

2.7

58.43

63.10

u/l

0.68

2970

23266

(3029937) Albumin [Presence] in Urine by Test strip

2937

22899

1.42

48.53

5.1

4.1

0.00

estimate

3.03

911

7946

(3002582) Erythrocytes [#/volume] in Urine

3311

26401

1.40

47.87

3.9

3.6

58.90

83.73

e6/l

1.17

2671

20200

(3019150) Specific gravity of Urine by Refractometry

2441

18572

1.43

45.66

5.2

4.0

1.02

1.18

kg/l

0.80

1642

12389

(3028271) Lactate [Moles/volume] in Capillary blood

299

1236

2.47

45.13

2.3

1.9

2.25

1.69

mmol/l

7.73

292

1209

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

106

235

4.55

44.13

1.4

1.2

25.00

24.64

0.01

(3021960) Folate [Moles/volume] in Serum or Plasma

2843

22372

1.39

43.32

1.8

1.7

18.78

19.93

nmol/l

4.02

2508

19159

(3000850) Epithelial cells [#/volume] in Urine

2389

18292

1.41

42.54

3.1

2.8

6.12

5.29

e6/l

1.87

2238

16651

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

11.67

42.01

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

159

488

3.30

41.82

1.0

373.13

310.65

ng/l

0.38

122

341

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

211

765

2.80

41.51

1.5

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

2883

22869

1.38

41.41

3.7

3.4

0.40

0.42

e6/l

0.21

2261

16814

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

157

492

3.23

39.93

1.0

38.08

41.38

ng/l

0.54

118

341

(3015736) pH of Urine

4012

33642

1.34

39.85

4.2

3.5

6.49

6.22

36.79

2170

18764

(3012501) Base excess in Blood by calculation

350

1647

2.17

39.05

4.5

2.39

2.50

mmol/l

0.33

245

1096

(3013290) Carbon dioxide [Partial pressure] in Blood

350

1648

2.17

38.99

4.5

5.08

4.99

kpa

1.42

340

1613

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

155

490

3.20

38.87

1.0

687.42

745.03

ng/l

0.78

115

332

(3027315) Oxygen [Partial pressure] in Blood

351

1657

2.16

38.85

4.5

8.72

8.66

kpa

0.26

341

1621

(3011397) Hemoglobin [Presence] in Urine by Test strip

2471

19292

1.39

38.48

4.5

3.8

0.26

0.38

0.15

201

(3039000) Anion gap in Blood by calculation

345

1627

2.16

38.28

12.1

6.6

11.06

11.37

mmol/l

0.93

312

1448

(3018572) Chloride [Moles/volume] in Blood

345

1628

2.16

38.22

12.1

6.6

104.63

105.04

mmol/l

0.65

312

1450

(3035350) Ketones [Presence] in Urine by Test strip

4846

41983

1.33

37.61

4.8

3.9

4.64

4.07

estimate

0.09

1012

8863

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3241

26485

1.35

37.53

4.3

3.4

32.50

34.38

u/l

0.61

3063

25026

(4198724) Urine methamphetamine measurement

132

389

3.43

37.07

1.7

3.1

—

(1616796) Gas panel - Central venous blood

375

1854

2.07

36.78

4.0

3.9

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

475

2556

1.90

36.55

2.7

3.2

3.40

3.53

g/l

1.08

453

2450

(40767503) Oxygen content in Capillary blood by calculation

350

1691

2.11

36.49

2.9

2.7

16.90

16.44

2.06

340

1660

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

512

2828

1.86

36.32

2.0

1.8

—

(3018095) Leukocytes [#/volume] in Urine

3605

30050

1.33

36.04

4.6

4.1

98.51

94.66

e6/l

0.06

2725

21228

(3010421) pH of Blood

470

2545

1.89

35.47

4.3

4.0

7.41

1.06

460

2513

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

6.51

35.23

1.5

1.1

50.41

59.86

0.57

(3019225) pH of Specimen

1060

7159

1.54

35.11

4.7

4.4

7.36

7.35

0.68

899

5133

(36304419) Bacteria [Presence] in Urine

2716

21782

1.35

34.98

3.7

3.4

1.41

152.22

estimate

0.62

102

(3019069) Monocytes/Leukocytes in Blood

4388

37723

1.32

34.78

7.8

6.9

9.16

8.86

8.44

4163

35392

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1357

9673

1.47

34.63

2.2

1.8

1.71

1.46

17.13

1215

8487

(3021601) Nitrite [Presence] in Urine by Test strip

4771

41513

1.31

34.55

4.8

3.9

0.00

estimate

1.60

973

8683

(3009261) Glucose [Presence] in Urine by Test strip

4843

42244

1.31

34.36

4.8

3.9

1.06

0.06

estimate

0.47

956

8364

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

135

425

3.21

34.14

1.1

1.11

1.15

u/l

0.18

181

(3047181) Lactate [Moles/volume] in Blood

443

2383

1.90

34.10

10.6

5.6

1.41

1.32

mmol/l

0.86

390

2097

(3006504) Eosinophils/Leukocytes in Blood

4372

37640

1.31

33.96

7.8

6.8

2.60

2.87

12.72

4149

35299

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1999

15353

1.39

33.58

4.5

4.0

239.04

500.98

ng/l

2.98

1569

11969

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

455

2488

1.87

33.29

1.3

—

(3022096) Basophils/Leukocytes in Blood

4361

37620

1.31

32.99

7.8

6.9

0.64

0.67

4.51

4142

35267

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

894

5890

1.57

32.95

1.8

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

473

2627

1.84

32.94

4.7

4.8

8.70

8.56

kpa

0.81

459

2566

(3028707) Methadone [Presence] in Urine by Screen method

316

1527

2.11

32.94

2.1

3.0

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

510

2911

1.80

32.47

3.0

3.2

24.54

24.68

mmol/l

0.37

503

2861

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

485

2730

1.82

32.34

3.5

3.8

0.36

0.34

iu/ml

0.81

316

1501

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

559

3293

1.74

31.92

2.4

1.9

2.81

2.35

ug/l

0.31

471

2914

(3002030) Lymphocytes/Leukocytes in Blood

4449

38681

1.29

30.87

7.8

6.8

26.61

27.90

11.37

4261

36668

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.22

30.78

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2665

21636

1.33

30.69

2.3

2.4

2.84

2.80

mg/l

0.44

2269

18802

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

517

8499

0.58

30.46

1.8

1.9

3.50

3.53

ratio

0.14

380

6483

(3018010) Neutrophils/Leukocytes in Blood

4368

37945

1.29

30.25

7.6

6.7

57.95

57.15

4.10

4209

36266

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1312

9576

1.43

29.11

4.5

4.6

251.66

242.30

u/l

0.76

1238

9090

(3019550) Sodium [Moles/volume] in Serum or Plasma

8032

76191

1.47

28.88

30.7

19.1

138.44

139.68

mmol/l

199.10

7932

74690

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5780

52305

1.29

27.90

4.7

3.4

66.27

46.95

u/l

22.37

5547

49254

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

115

377

3.08

27.25

1.9

2.3

138.82

153.56

umol/l

0.20

201

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

359

6322

0.55

27.07

1.6

3.45

3.46

mmol/l

0.08

233

4312

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

425

2432

1.78

26.80

2.7

3.1

187.46

190.82

0.34

403

2326

(3022806) Fractional oxyhemoglobin in Capillary blood

208

925

2.28

26.73

2.2

1.9

89.35

89.73

0.47

202

914

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.58

26.53

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

126

4.70

25.84

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

125

443

2.85

25.81

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

544

3368

1.65

25.76

5.0

4.8

24.83

24.67

mmol/l

0.64

502

3115

(3045716) Anion gap in Serum or Plasma by calculation

193

845

2.31

25.74

3.1

3.2

11.18

10.64

mmol/l

0.72

193

831

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6881

73007

0.76

25.44

4.9

1.46

1.43

mmol/l

5.25

6436

68168

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2155

17367

1.32

25.17

2.0

1.9

1.22

1.27

mg/l

0.24

1698

13411

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

236

1133

2.11

25.09

5.5

6.7

10.63

11.76

mg/l

3.31

210

1051

(40758558) Short blood count panel - Blood

2852

23862

1.28

25.04

8.2

6.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7048

74504

0.76

25.03

5.7

5.6

2.62

2.69

mmol/l

9.03

6602

69696

(3007853) Bacteria identified in Skin by Aerobe culture

1292

9651

1.39

24.79

1.9

1.8

—

(3021901) Oxygen saturation in Capillary blood

325

1760

1.88

24.53

2.9

3.2

90.43

89.90

0.61

315

1718

(3023103) Potassium [Moles/volume] in Serum or Plasma

8014

76366

1.42

24.43

30.1

19.3

3.97

3.98

mmol/l

0.49

7900

74730

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

111

380

2.94

24.43

2.6

2.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

502

3100

1.65

24.00

2.1

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3624

31355

1.26

23.75

4.9

3.8

0.76

0.19

estimate

0.44

820

7181

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

100

5.02

23.66

1.1

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.02

23.27

1.3

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1809

14369

1.32

23.14

3.3

3.1

1.20

1.30

e6/l

0.17

1024

7717

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

439

2657

1.68

22.67

2.5

3.2

95.85

92.47

2.12

422

2573

(3022313) Gas panel - Capillary blood

625

4130

1.55

22.50

4.8

4.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3940

34559

1.25

22.44

2.3

2.1

94.34

95.56

pmol/l

0.89

2240

18689

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

8.31

22.22

1.8

1.2

25.71

35.52

0.47

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

102

4.82

22.15

1.1

1.0

—

(21494755) Public health laboratory ask at order entry panel

459

7212

0.62

22.13

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2768

23360

1.27

21.95

3.3

3.4

1388.83

1492.50

ng/l

0.56

2430

20171

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2005

16260

1.30

21.86

1.7

31147029.65

29190012.78

pmol/l

0.06

1692

13635

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6962

73436

0.77

21.61

5.0

4.54

4.58

mmol/l

2.40

6542

68976

(3005719) IgG [Mass/volume] in Serum or Plasma

887

6359

1.44

21.32

2.6

2.9

10.22

10.52

g/l

1.00

813

5878

(3014271) Vancomycin [Susceptibility]

100

349

2.88

21.31

3.0

2.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

721

4994

1.48

20.73

1.3

46.42

53.86

au/ml

0.38

325

(3042936) Bacteria identified in Isolate by Culture

1467

11472

1.33

20.67

2.2

2.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

18.29

20.35

1.1

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

767

5409

1.46

20.10

2.4

25.64

20.29

au/ml

0.78

593

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1047

7842

1.38

19.46

2.5

2.4

0.21

g/l

0.50

976

7315

(3027945) Reticulocytes/Erythrocytes in Blood

1263

9756

1.34

19.24

3.1

2.8

1.82

1.76

1.41

1121

8704

(44816559) Phosphatidylethanol [Mass/volume] in Blood

525

3457

1.55

19.18

2.0

1.7

0.32

0.31

mg/l

0.14

278

1635

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2719

31506

0.80

19.11

1.9

1.36

mmol/l

0.07

2353

26721

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.17

18.88

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.80

18.32

1.2

1.1

11.83

20.06

—

(3040151) Glucose [Moles/volume] in Capillary blood

191

957

2.02

18.21

9.0

6.5

7.41

7.28

mmol/l

0.19

168

808

(3023520) Reticulocytes [#/volume] in Blood

999

7508

1.37

18.12

2.9

2.7

70.35

69.02

e9/l

0.52

728

5458

(40757494) Bilirubin.total [Moles/volume] in Blood

104

406

2.58

17.94

2.3

2.5

42.24

53.20

umol/l

0.19

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7891

75637

1.33

17.78

25.4

16.3

24.53

24.80

mg/l

0.33

7073

62381

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1631

13183

1.29

17.76

3.5

3.3

3.48

2.32

e6/l

3.23

842

6509

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

155

730

2.14

17.45

2.6

3.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.34

16.79

1.8

1.9

—

(44790048) Parainfluenza type 2 nucleic acid detection

204

1080

1.91

16.62

1.4

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

204

1080

1.91

16.62

1.4

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

204

1080

1.91

16.62

1.4

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

204

1080

1.91

16.62

1.4

1.6

—

(4034850) Laboratory test

368

2307

1.62

16.60

12.6

10.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

910

6831

1.37

16.57

2.4

2.6

66.06

66.28

g/l

0.34

820

6262

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

298

2.77

16.32

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

353

2212

1.62

15.96

3.7

3.3

2.76

2.09

index

0.57

205

1164

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

123

3.83

15.93

1.0

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

347

2188

1.61

15.31

1.7

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

324

2016

1.63

15.09

2.4

2.3

133.19

129.47

g/l

2.22

277

1558

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6281

59023

1.21

14.59

4.8

4.3

14.40

14.78

pmol/l

25.31

5823

54313

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

218

1231

1.79

14.52

1.3

3.90

4.38

u/ml

0.22

109

572

(3024928) Oxygen saturation in Venous blood

340

2165

1.59

14.42

3.2

3.8

62.02

62.15

0.04

324

2100

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

274

1655

1.68

14.35

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

274

1655

1.68

14.35

1.4

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

302

1871

1.63

14.33

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

358

2324

1.56

13.98

1.7

—

(3021589) Normoblasts [#/volume] in Blood

3916

35366

1.19

13.98

14.1

11.8

0.00

e9/l

0.50

3180

28661

(3030981) Hyaline casts [#/volume] in Urine by Automated count

869

6644

1.34

13.97

2.8

2.6

0.50

0.44

e6/l

0.31

839

6386

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

170

3.19

13.89

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

126

3.58

13.89

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

101

444

2.29

13.56

1.8

2.3

15.86

16.17

0.42

101

444

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

100

439

2.29

13.47

1.2

1.1

1643.30

1501.83

miu/ml

0.58

100

439

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

328

2106

1.58

13.45

1.6

—

(3011985) Renin [Units/volume] in Plasma

201

1140

1.78

13.23

1.6

1.5

60.17

72.57

mu/l

0.40

185

1020

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

812

6202

1.34

13.12

4.4

4.1

1.22

1.23

mmol/l

6.82

757

5356

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6644

69566

0.83

12.94

4.3

4.2

1.29

mmol/l

0.04

6171

64345

(1001926) Buprenorphine [Presence] in Urine by Screen method

414

2858

1.47

12.12

2.1

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

151

807

1.89

12.08

3.4

4.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.40

11.87

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1304

15689

0.80

11.77

3.0

3.2

0.77

0.78

ug/l

0.11

909

10246

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

211

1256

1.70

11.75

1.3

5.98

3.51

u/ml

0.77

445

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.23

11.70

1.1

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

263

1665

1.60

11.50

1.7

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

288

1869

1.56

11.33

1.6

1.7

—

(3045414) Leukocytes [Presence] in Urine

950

7566

1.28

11.28

2.2

2.1

0.01

estimate

0.54

168

1565

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

397

2759

1.46

11.25

2.6

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

436

2.17

11.17

1.7

2.0

7.82

7.90

mmol/l

0.06

436

(3011412) CD3 cells [#/volume] in Blood

151

829

1.83

11.14

2.4

2.7

1130.87

1189.19

e6/l

0.30

132

702

(3019230) Fractional oxyhemoglobin in Venous blood

284

1845

1.56

11.13

3.0

3.7

61.56

62.54

0.32

284

1839

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

523

3834

1.39

10.99

1.7

1.48

1.51

g/l

0.38

423

3323

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

427

2.17

10.92

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

159

2727

0.58

10.87

1.1

0.63

0.64

ratio

0.08

330

(3008037) Lactate [Moles/volume] in Venous blood

295

1949

1.53

10.73

4.0

3.3

1.72

1.59

mmol/l

0.78

287

1892

(3016879) Cocaine [Presence] in Urine

469

3393

1.40

10.66

2.1

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

182

1075

1.71

10.48

1.2

1.3

834.35

344.70

pmol/l

0.43

159

909

(3011288) Drugs identified in Urine by Screen method Nominal

363

2516

1.46

10.45

3.0

3.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

218

1351

1.63

10.45

3.1

3.8

1.56

1.58

0.02

199

1197

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

131

3.14

10.38

2.3

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

189

1137

1.68

10.18

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

970

7844

1.26

10.14

4.3

3.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

376

2.16

9.67

1.7

2.0

157.82

148.95

0.41

361

(3028433) Virus identified in Specimen by Culture

263

2.40

9.63

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1660

14274

1.20

9.60

2.6

2.7

12.76

13.03

umol/l

0.74

1526

13325

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

139

2.96

9.42

2.2

2.0

—

(3027008) Opiates [Presence] in Urine

489

3645

1.36

9.30

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

225

1447

1.57

9.29

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

487

3629

1.36

9.28

2.0

2.2

—

(3028300) Cannabinoids [Presence] in Urine

489

3652

1.36

9.19

2.1

2.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6743

70000

0.86

9.14

6.4

6.3

38.85

39.20

mmol/mol

2.41

6322

65774

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

314

2175

1.46

9.12

1.2

3.01

4.08

1.17

275

(3001019) Free T4 and TSH panel - Serum or Plasma

247

3652

0.67

8.93

1.7

—

(3045424) Erythrocytes [Presence] in Urine

509

3849

1.34

8.82

2.3

2.1

0.02

0.22

estimate

0.48

139

1196

(4268621) Lupus anticoagulant assay

151

891

1.71

8.80

2.4

2.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1549

13341

1.19

8.72

2.6

2.7

2.27

2.32

g/l

2.68

1426

12344

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

174

1069

1.64

8.71

1.4

1.3

24.30

25.50

u/l

0.21

145

888

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

346

2463

1.42

8.69

2.2

1.7

0.23

g/l

0.84

336

2347

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

355

2539

1.41

8.68

2.2

1.7

1.18

g/l

0.08

344

2424

(3017354) Segmented neutrophils/Leukocytes in Blood

146

860

1.71

8.58

2.7

3.7

59.83

56.90

0.94

127

735

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

16.27

8.54

1.2

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

235

1557

1.52

8.52

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

388

2830

1.39

8.47

3.7

3.6

303.01

408.02

mg/l

1.29

219

1360

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

110

602

1.84

8.32

2.3

2.8

506.80

504.30

e6/l

0.02

468

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.24

8.31

1.8

4.1

—

(40757373) Influenza virus identified in Isolate

145

2.77

8.19

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

111

615

1.81

8.08

2.4

3.0

212.48

215.22

e6/l

0.05

502

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

172

1077

1.61

8.01

1.7

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

300

2.17

7.95

3.0

2.5

140.84

144.97

nmol/l

0.15

261

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

181

1150

1.58

7.94

1.2

1.1

117.08

114.68

0.42

161

1041

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

13.01

7.86

1.2

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

192

1240

1.56

7.85

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

176

1115

1.59

7.82

1.3

0.22

0.26

nmol/l

0.30

(3027944) Amphetamines [Presence] in Urine

472

3597

1.33

7.79

2.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

114

648

1.77

7.64

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

114

648

1.77

7.64

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

114

648

1.77

7.64

1.5

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

152

935

1.64

7.63

1.2

1.3

0.18

0.20

nmol/l

0.57

122

750

(3002179) Metamyelocytes/Leukocytes in Blood

841

6913

1.24

7.58

4.4

4.5

0.87

0.71

1.31

338

2100

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

255

2.24

7.54

1.5

13.22

15.38

pmol/l

1.66

216

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

472

1.89

7.47

2.7

2.6

42.84

39.91

0.74

256

(3017181) Myelocytes/Leukocytes in Blood

876

7246

1.23

7.45

4.7

4.6

1.16

0.94

1.54

351

2196

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

609

4833

1.28

7.44

3.0

3.4

4.28

4.52

pmol/l

7.49

556

4331

(1175426) CD3 cells/Lymphocytes in Blood

119

691

1.73

7.42

2.2

2.5

74.97

71.28

1.88

114

659

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5971

57033

1.14

7.41

4.6

4.4

12.35

11.88

mm/h

1.52

5646

53432

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

115

665

1.74

7.29

2.4

2.5

—

(3052592) Norovirus Ag [Presence] in Stool

138

2.69

7.22

1.8

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

131

789

1.67

7.16

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1417

12306

1.18

7.14

2.7

2.8

22.56

22.52

0.03

1300

11451

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

769

6305

1.24

7.10

3.4

2.7

70.45

66.76

ml/min/173m2

1.44

336

2681

(3051651) Icteric interference index of Serum or Plasma

459

1.88

7.10

2.6

3.8

0.66

0.91

index

2.32

451

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3805

35434

1.13

6.98

2.6

2.5

74.14

76.60

nmol/l

5.99

3434

32300

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

210

1421

1.49

6.96

3.0

3.9

603.20

1551.34

u/ml

0.79

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

231

1598

1.46

6.86

1.4

—

(3013512) EKG study

2831

25937

1.13

6.72

4.4

3.7

1.00

0.73

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

130

799

1.64

6.61

2.9

3.1

20.51

20.52

nmol/l

0.00

117

768

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

7.78

6.60

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

253

1800

1.42

6.48

5.5

6.3

311.89

1993.32

iu/ml

1.03

265

(40760892) CBC W Ordered Manual Differential panel - Blood

2002

17971

1.15

6.45

5.7

4.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

141

890

1.59

6.44

1.2

1.1

91.72

96.92

1.48

127

838

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.92

6.40

1.3

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

258

3552

0.72

6.37

1.5

1.6

1191.65

999.30

mu/l

0.76

214

3019

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

513

1.78

6.35

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

509

1.78

6.22

2.8

3.2

92.55

98.31

0.83

485

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

245

2.13

6.13

1.1

84.56

89.30

0.35

128

(3023419) Bacteria identified in Sputum by Culture

154

1005

1.54

6.11

2.4

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

313

2335

1.35

6.04

1.3

—

(4195642) Thrombophilia screening test

171

1146

1.50

6.01

1.3

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

436

1.82

5.94

11.6

13.7

0.60

0.62

mmol/l

0.28

401

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

503

1.76

5.89

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

417

1.83

5.83

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

360

1.89

5.83

1.2

1.3

157.96

166.75

mmol/24h

0.32

360

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

179

1220

1.48

5.80

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

161

2.37

5.77

1.1

1.2

65.50

78.78

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

252

2.07

5.72

1.2

98.13

101.54

0.26

233

(3009445) Proteinase 3 Ab [Units/volume] in Serum

439

3467

1.28

5.64

1.6

17.79

16.94

iu/ml

0.04

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

247

2.07

5.63

3.3

3.2

4.86

4.83

kpa

0.06

247

(3035285) Chloride [Moles/volume] in Venous blood

136

881

1.55

5.62

3.3

2.3

104.77

105.57

mmol/l

1.05

136

871

(3021440) Promyelocytes/Leukocytes in Blood

820

6933

1.20

5.60

4.8

4.7

0.16

0.11

0.88

299

1894

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

241

2.08

5.59

1.1

1.2

77.53

88.42

0.90

129

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

248

2.06

5.57

3.3

3.2

9.95

10.48

kpa

0.82

248

(3041354) Potassium [Moles/volume] in Venous blood

136

883

1.55

5.56

3.3

2.3

4.06

4.07

mmol/l

0.18

136

873

(3049233) Organic acids panel - Urine

5.84

5.51

1.4

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.99

5.51

1.5

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

133

862

1.55

5.49

3.4

2.4

1.20

mmol/l

0.04

133

852

(3039443) Prostate specific Ag panel - Serum or Plasma

1383

0.59

5.47

1.5

1.6

—

(3037756) Immunofixation for Serum or Plasma

230

1669

1.39

5.33

1.4

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

732

6153

1.21

5.33

3.8

4.3

82.67

90.69

ng/l

1.73

626

5357

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

161

2.30

5.32

1.1

1.2

74.67

71.67

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1089

9475

1.17

5.32

3.2

3.0

7.37

8.39

umol/l

1.20

917

8296

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

900

7723

1.18

5.20

2.7

2.6

42.98

44.56

u/l

0.07

761

6538

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

385

3034

1.28

5.07

2.6

2.4

7404.00

5612.66

u/l

0.41

121

1190

(3021387) Prolactin [Units/volume] in Serum or Plasma

372

2927

1.28

4.97

1.8

1.7

350.16

291.71

mu/l

2.36

338

2668

(3051611) Lipemic interference index of Serum or Plasma

119

771

1.55

4.96

3.1

3.5

13.37

13.38

index

0.00

452

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

288

1.91

4.93

1.8

2.0

179.29

172.17

0.21

275

(3025159) Blasts/Leukocytes in Blood

822

7033

1.19

4.93

5.0

4.8

0.23

0.30

0.16

282

1830

(3000494) Fungus identified in Specimen by Culture

1096

9603

1.16

4.88

1.5

—

(3044889) 12 lead EKG panel

5476

52611

1.10

4.78

4.5

4.1

0.53

4159.53

0.73

104

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

374

2963

1.27

4.74

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

339

2653

1.29

4.74

1.5

10.76

9.12

u/l

1.21

272

2060

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.42

4.73

2.3

5.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

570

1.62

4.66

1.1

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.52

4.54

2.1

4.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

279

2142

1.31

4.52

1.5

—

(3006245) CD3-CD19+ cells/cells in Blood

402

1.72

4.43

2.3

3.0

10.03

11.93

0.42

381

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

558

1.60

4.33

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

594

4998

1.20

4.32

1.8

2.0

1.25

1.30

g/l

0.35

533

4607

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.34

4.31

1.1

1.57

5.20

u/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

361

1.75

4.29

2.1

1.7

1.25

3.30

u/field

2.14

255

(3028717) Thiamine [Mass/volume] in Blood

113

2.39

4.29

1.1

1.3

64.07

64.74

ug/l

0.04

113

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

142

2012

0.70

4.28

1.4

1.5

51.98

60.60

ug/l

1.44

113

1689

(40768800) Prostate Pathology biopsy report

114

1676

0.68

4.21

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

109

2.39

4.13

1.0

1.4

42.12

73.62

ng/l

0.62

(3042517) Benzodiazepines panel - Urine

2.53

4.11

3.9

2.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

268

2076

1.30

4.11

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

269

2086

1.30

4.09

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

266

2062

1.30

4.06

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

141

990

1.43

4.04

1.1

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

172

2334

0.73

4.01

1.6

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

384

1.70

4.00

2.4

2.7

28.30

28.27

0.01

368

(21494814) CD8 cells/Lymphocytes in Specimen

311

1.77

3.95

2.1

2.2

32.02

31.41

0.11

311

(3023420) DNA double strand Ab [Units/volume] in Serum

397

3241

1.23

3.94

2.2

1.8

6.76

6.81

iu/ml

0.01

105

777

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

133

1875

0.70

3.93

1.4

1.5

0.96

0.94

ratio

0.21

1124

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

133

1873

0.71

3.91

1.4

1.5

1.06

1.15

ratio

0.51

1122

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

144

2.16

3.91

1.3

1.2

0.90

149.84

mg/l

1.69

106

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

131

1847

0.70

3.88

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

209

2741

0.76

3.88

1.6

1.7

6.00

4.50

mg/l

0.66

166

2006

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

134

1875

0.71

3.80

1.4

1.5

1.18

1.21

ratio

0.13

1131

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

196

1473

1.34

3.76

1.3

330.67

359.07

titre

0.05

108

(3023511) Choriogonadotropin [Units/volume] in Urine

190

1422

1.34

3.75

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

354

1.70

3.74

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

354

1.70

3.74

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

339

1.71

3.74

3.4

3.5

1.07

1.33

0.67

339

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

304

2425

1.26

3.73

2.8

3.3

5.84

3.56

ratio

0.34

196

1411

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1956

21109

0.91

3.64

4.3

4.5

21.65

22.14

0.70

989

10353

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

131

928

1.42

3.62

1.7

364.96

341.31

mu/l

0.34

108

738

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7145

69877

1.10

3.62

6.0

5.2

1.83

1.91

mu/l

6.01

6696

64885

(3022493) Free Hemoglobin [Mass/volume] in Plasma

373

1.67

3.61

4.7

4.8

76.42

65.82

mg/l

0.62

268

(3020911) Cortisol [Moles/time] in 24 hour Urine

271

1.77

3.51

1.5

1.4

134.08

311.36

nmol/24h

0.84

271

(3047352) Trisomy 18 risk [Likelihood] in Fetus

108

1543

0.70

3.49

1.4

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.61

3.48

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1186

13113

0.89

3.46

1.3

19.15

10.65

u/ml

0.89

476

5090

(4094501) Cardiovascular stress test using bicycle ergometer

155

2082

0.74

3.44

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

600

1.50

3.42

1.4

12.98

12.89

u/l

0.04

576

(3043238) Trisomy 21 risk [Likelihood] in Fetus

112

1580

0.70

3.38

1.5

1.6

—

(1002224) Polysomnography panel

301

3704

0.81

3.36

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

115

808

1.43

3.36

1.2

—

31.80

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.72

3.33

1.0

1.1

2.85

1.23

mg/l

—

(3005033) Fetal Nuchal fold Thickness US

107

1514

0.70

3.29

1.4

1.5

1.35

1.25

1.19

1092

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

353

1.65

3.27

1.1

26.14

14.37

u/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

369

3057

1.22

3.24

1.3

1.2

0.53

0.92

u/ml

0.75

251

(3002256) Pathology report gross observation

926

10350

0.88

3.24

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

283

2282

1.25

3.21

1.4

1.5

10.50

12.87

iu/ml

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

139

1018

1.37

3.21

1.4

—

(3008898) HLA-B27 [Presence]

218

2763

0.78

3.17

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

403

1.59

3.16

1.1

1.2

334.96

332.75

u/l

0.01

370

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2485

26373

0.92

3.13

4.9

5.5

3.41

3.04

ug/l

0.32

2220

23920

(3000060) B lymphocytes [#/volume] in Blood

319

1.66

3.13

2.2

2.9

0.97

0.47

e9/l

0.25

161

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

329

2705

1.22

3.13

3.0

3.4

42.01

52.94

mg/l

0.46

285

2307

(3028308) Erythrocytes [#/volume] in Pleural fluid

123

888

1.39

3.11

1.4

1.5

91989.13

58437.14

e6/l

0.54

495

(3006922) Hepatitis E virus Ab [Presence] in Serum

630

1.46

3.10

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

329

2708

1.22

3.10

3.0

3.4

49.29

75.52

mg/l

0.67

285

2310

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1389

15122

0.90

3.05

1.7

1.6

—

(3022145) Colonoscopy Study observation

795

8927

0.88

3.00

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

135

1000

1.35

2.93

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

169

1.90

2.93

1.1

1.2

309.27

270.22

pmol/l

0.30

119

(3038177) Helicobacter pylori Ab [Presence] in Serum

1278

0.70

2.88

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

164

1.89

2.84

2.6

2.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

126

1687

0.74

2.81

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

282

2311

1.23

2.80

1.2

1.3

116.67

142.37

titre

0.19

207

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

146

1103

1.33

2.80

1.8

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

223

1.75

2.80

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

276

1.67

2.78

3.1

2.7

0.61

mmol/l

0.15

276

(3024522) Salmonella sp identified in Specimen by Organism specific culture

134

1001

1.34

2.78

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

371

3130

1.19

2.74

2.1

2.3

2.86

2.92

g/l

0.51

322

2852

(3025468) Yersinia sp identified in Specimen by Organism specific culture

129

963

1.34

2.70

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.59

2.69

1.2

1.0

—

(3003694) ABO and Rh group [Type] in Blood

2427

22915

1.08

2.69

1.4

1.5

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

990

0.67

2.68

3.9

2.7

13.39

13.14

0.99

977

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

711

6315

1.14

2.68

3.1

3.2

168.67

212.04

ng/l

2.89

651

5750

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

395

3358

1.18

2.68

1.8

1.9

39.31

39.70

u/l

0.13

356

2997

(3003129) Base excess in Capillary blood by calculation

127

947

1.35

2.68

2.3

2.4

1.26

0.41

mmol/l

2.19

120

902

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

123

913

1.35

2.67

1.9

2.1

39.97

23.33

mg/l

1.70

320

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

397

1.54

2.67

1.4

1.6

2.54

6.90

nmol/l

1.59

309

(3023199) Leukocytes [#/volume] in Pleural fluid

134

1008

1.33

2.67

1.4

1.5

2115.59

3258.55

e6/l

0.63

108

701

(3003434) Protein [Mass/volume] in Pleural fluid

151

1156

1.31

2.66

1.4

1.5

34.05

32.02

g/l

1.18

144

1047

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

168

1.85

2.66

3.0

2.8

350.81

250.68

ug/l

0.10

168

(3017732) Neutrophils [#/volume] in Blood

1102

10051

1.11

2.64

3.8

3.2

4.24

4.59

e9/l

1.45

945

8704

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.14

2.64

1.2

1.6

28.85

33.69

nmol/l

0.10

(3035947) Staphylolysin Ab [Units/volume] in Serum

367

1.56

2.62

1.1

4.20

4.00

iu/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

169

1317

1.29

2.62

1.5

1.9

4.74

4.88

mmol/24h

0.25

150

1169

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

129

969

1.34

2.60

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.25

2.60

1.6

1.3

1.12

1.39

iu/ml

0.56

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

170

1.83

2.57

3.0

2.4

1.87

1.59

mmol/l

0.15

119

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

474

1.48

2.56

1.1

0.13

11.61

nmol/l

—

102

(3005988) Vibrio sp identified in Specimen by Organism specific culture

129

972

1.33

2.55

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

340

1.56

2.49

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

618

1.41

2.49

1.2

1.3

11.38

12.67

u/l

0.52

567

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

594

1.42

2.47

2.2

2.0

2.08

1.43

u/field

0.55

326

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

233

1.68

2.44

1.5

1.4

133.89

127.47

nmol/l

0.09

171

(3034770) Mitochondria Ab [Titer] in Serum

275

2287

1.21

2.41

1.2

1.3

706.67

1016.45

titre

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

389

3338

1.17

2.40

2.1

2.3

4.15

4.20

g/l

0.70

340

3060

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

389

3341

1.17

2.37

2.1

2.3

7.18

7.39

g/l

1.61

340

3059

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.21

2.36

2.9

2.4

0.65

0.55

u/field

0.15

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7013

71266

0.93

2.32

5.2

5.1

5.88

5.93

mmol/l

2.44

6487

65720

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

167

1322

1.27

2.32

1.2

1.1

7895.85

7845.36

iu/ml

0.00

305

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

387

3334

1.17

2.29

2.1

2.3

3.57

3.74

g/l

1.23

339

3057

(3015076) Soybean IgE Ab [Units/volume] in Serum

510

0.59

2.28

1.1

2.39

2.23

u/ml

—

162

(3000963) Hemoglobin [Mass/volume] in Blood

8151

82292

0.90

2.27

37.8

24.7

132.55

135.46

g/l

60.94

8087

81449

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

405

1.48

2.27

1.6

1.5

3043117.80

1431035.95

iu/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

156

1229

1.27

2.27

1.5

0.32

0.38

nmol/l

0.51

123

943

(3026361) Erythrocytes [#/volume] in Blood

8150

82278

0.90

2.25

37.4

24.5

4.38

4.51

e12/l

92.15

8016

80343

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8150

82273

0.90

2.23

38.2

25.0

39.53

40.82

15.15

8079

81372

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8150

82270

0.90

2.22

37.4

24.5

91.21

90.87

9.14

8080

81415

(3035941) MCH [Entitic mass]

8150

82269

0.90

2.21

37.3

24.4

30.52

30.28

27.59

8079

81416

(3044009) aPTT.lupus sensitive (LA screen)

2.33

2.21

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

107

1.96

2.19

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

8153

82290

0.90

2.17

37.5

24.6

6.80

6.78

e9/l

0.25

8021

80333

(3033086) Enterovirus Ab [Titer] in Serum

3.33

2.17

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

100

1326

0.75

2.17

1.5

1.6

54.44

59.46

ug/l

0.79

100

1326

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

289

1.56

2.15

1.0

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

122

939

1.30

2.14

1.1

—

(3019174) dRVVT (LA screen)

2.30

2.14

1.1

1.2

—

(3007461) Platelets [#/volume] in Blood

8150

82253

0.91

2.14

37.5

24.6

247.55

250.08

e9/l

2.83

8033

80560

(3034426) Prothrombin time (PT)

259

1.59

2.10

1.2

30.59

28.49

1.02

259

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

290

2459

1.18

2.10

1.4

1.3

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.05

2.10

1.0

0.00

0.56

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

167

1.74

2.10

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

102

1.96

2.09

1.3

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

138

1.81

2.08

1.2

1.1

0.77

0.69

umol/24h

0.31

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.13

2.08

4.1

3.7

10.37

3.68

—

(3045788) Cell count panel - Pleural fluid

108

822

1.32

2.06

1.4

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1323

14175

0.92

2.05

1.3

30.17

30.72

iu/ml

0.05

361

4178

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

309

1.52

2.04

1.4

2.1

327.40

42324.72

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

1638

0.78

2.04

1.1

2.62

2.18

u/ml

0.13

916

(3020874) Milk IgE Ab [Units/volume] in Serum

578

0.64

2.02

1.1

1.2

0.83

2.57

u/ml

1.36

230

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.63

2.00

1.6

1.5

486.31

503.52

nmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

140

1109

1.27

1.99

1.4

—

(4024509) Urine culture

409

3583

1.15

1.97

2.2

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.33

1.96

1.0

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

869

7960

1.10

1.96

4.2

4.3

13.16

28.80

ug/l

1.92

714

6487

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

171

1.70

1.95

1.1

—

22.14

u/ml

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

206

1708

1.21

1.93

1.5

1.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

570

0.65

1.91

1.2

2.04

8.89

u/ml

—

190

(3005082) Progesterone [Moles/volume] in Serum or Plasma

410

0.58

1.91

1.3

1.5

27.79

37.00

nmol/l

0.84

366

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

282

1.53

1.91

1.2

935.71

998.25

titre

0.11

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

274

1.53

1.91

1.2

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

1195

11119

1.09

1.90

1.4

507.42

514.87

titre

0.05

248

2292

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

162

1313

1.24

1.90

1.1

1.2

0.41

1.12

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.65

1.86

1.0

1.2

225.11

295.88

nmol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

244

1.56

1.86

1.3

28.59

269.14

ug/l

1.27

116

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

254

1.54

1.80

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

191

1.62

1.80

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.57

1.79

1.0

1.1

—

26.59

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.04

1.79

1.0

1.3

—

mmol/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2440

25466

0.94

1.77

4.1

4.3

11.81

9.23

mg/mmol

1.41

1603

16310

(3013336) Amino acids [Identifier] in Serum or Plasma

2.34

1.77

5.5

3.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

484

0.64

1.73

1.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1746

16543

1.07

1.72

1.6

1.5

2.35

2.38

g/l

0.24

1072

10239

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

180

2158

0.83

1.71

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7998

79171

1.08

1.70

16.7

12.0

26.23

26.60

u/l

0.73

7853

76939

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

315

1.46

1.70

1.1

93.05

93.54

0.03

243

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.06

1.69

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

175

1452

1.21

1.68

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

108

850

1.27

1.67

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

685

7480

0.91

1.66

2.4

2.3

12.63

13.06

nmol/l

0.67

608

6762

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

329

2881

1.15

1.65

2.1

2.4

0.74

0.87

g/l

0.29

271

2475

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

608

0.69

1.64

1.1

14.24

17.98

u/ml

0.27

231

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

166

1994

0.83

1.63

1.2

1.1

3.04

2.37

u/ml

0.27

1136

(3012516) Albumin [Mass/volume] in Urine

2401

25012

0.94

1.62

3.5

3.6

57.46

52.22

mg/l

0.54

1643

16392

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

378

0.61

1.62

1.7

1.9

8.29

3.27

u/ml

—

117

(3013139) Helicobacter pylori Ag [Presence] in Stool

477

5299

0.89

1.62

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.50

1.59

1.0

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

106

1.79

1.58

1.6

2.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8061

79863

1.08

1.55

31.1

20.8

74.76

78.61

umol/l

16.64

7973

78903

(3014133) Dog dander IgE Ab [Units/volume] in Serum

110

1370

0.80

1.55

1.1

2.78

3.88

u/ml

0.42

720

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

990

0.77

1.54

1.2

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.03

1.53

1.5

1.4

0.19

0.59

iu/ml

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1036

9681

1.08

1.52

1.7

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

161

1.62

1.51

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

445

3998

1.12

1.51

1.2

1.1

253.00

142.80

titre

—

120

(3019420) Tryptase [Mass/volume] in Serum or Plasma

468

1.35

1.50

1.4

1.5

6.89

9.65

ug/l

0.78

419

(3037692) Legionella sp identified in Specimen by Organism specific culture

266

1.47

1.50

1.4

1.5

—

(3044927) Protein electrophoresis panel - Urine

766

1.27

1.49

1.4

1.1

—

(3012441) Differential panel - Pleural fluid

111

891

1.25

1.49

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

308

1.43

1.48

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

513

1.33

1.47

1.8

2.9

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

216

0.51

1.46

1.3

1.1

17.44

59.15

u/ml

5.41

209

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

235

1.49

1.46

1.1

—

4.00

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

235

1.49

1.46

1.2

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.37

1.45

1.1

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

245

2125

1.16

1.44

1.9

2.0

12.20

11.83

mg/l

0.28

225

1989

(3026493) Urate [Moles/volume] in Serum or Plasma

2005

20927

0.95

1.44

3.0

2.8

326.60

346.34

umol/l

13.10

1743

18542

(3016135) IgD [Mass/volume] in Serum

3.12

1.43

1.0

1.2

21.40

33.73

mg/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

503

4566

1.11

1.43

1.9

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

404

1.36

1.42

27.9

108.09

115.21

ug/l

0.40

332

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1008

0.78

1.40

1.3

6.69

7.24

mmol/l

1.12

892

(3004451) EKG impression Narrative

457

1.34

1.40

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

157

1.59

1.40

1.4

1.9

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

380

1.37

1.39

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

410

0.66

1.38

8.5

6.0

37.80

9725.48

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

115

936

1.23

1.38

2.6

2.5

29.72

26.88

iu/ml

0.13

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

158

1.58

1.36

1.1

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

324

2878

1.13

1.36

2.2

2.3

10.22

10.23

g/l

0.00

273

2571

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

258

2939

0.87

1.36

1.5

1.6

23.50

15.23

u/ml

0.67

720

(40761536) Microorganisms panel - Urine sediment

683

6310

1.09

1.35

4.9

4.0

—

(40768806) Pleura Pathology biopsy report

108

876

1.24

1.35

1.4

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

254

2223

1.15

1.34

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

350

1.37

1.32

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

999

0.79

1.32

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1954

18729

1.05

1.31

1.4

1.89

1.90

u/ml

0.02

539

5015

(3002523) Influenza virus A Ag [Presence] in Specimen

127

1526

0.83

1.31

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

127

1526

0.83

1.31

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

127

1523

0.83

1.29

1.9

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

267

2353

1.14

1.28

2.1

2.3

0.01

0.00

g/l

0.46

221

2070

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.88

1.28

2.2

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

276

1.41

1.27

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

276

1.41

1.27

2.1

2.2

—

(4281824) Cell count and differential, peritoneal fluid

759

0.76

1.27

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

277

1.41

1.25

2.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

594

5479

1.09

1.24

2.1

2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

574

5288

1.09

1.23

1.2

90.64

138.76

u/ml

3.09

216

1933

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.04

1.21

2.4

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.04

1.21

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1119

0.81

1.21

1.1

2.27

3.37

eliau/ml

0.94

501

(3042111) Morphology [Interpretation] in Bone marrow Narrative

160

1367

1.17

1.19

1.8

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1183

0.82

1.19

1.0

1.1

0.17

0.39

u/ml

0.70

429

(3012494) Peanut IgE Ab [Units/volume] in Serum

274

0.62

1.17

1.0

1.2

11.14

16.73

u/ml

—

173

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

636

5904

1.08

1.16

1.6

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

227

1998

1.14

2.1

1.9

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

275

2452

1.12

1.13

2.0

2.3

0.04

g/l

0.12

240

2209

(3042631) Mycobacterium sp identified in Specimen

124

1042

1.19

1.13

2.6

2.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

607

1.25

1.13

2.1

1.6

30.70

24.84

u/ml

0.51

115

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.68

1.13

1.7

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

111

0.45

1.12

1.0

1.3

—

(3020491) Glucose [Moles/volume] in Blood

572

1.26

1.12

1.6

2.0

7.56

6.44

mmol/l

1.75

412

(3017704) Immunofixation for Urine

422

1.30

1.12

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

275

2456

1.12

1.11

1.4

261.76

273.22

ug/g

0.42

163

1445

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

672

1.24

1.10

1.2

232.14

199.27

titre

0.15

124

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

672

1.24

1.10

1.2

1.3

—

145.45

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2327

22497

1.05

1.10

4.2

3.3

0.13

0.19

estimate

0.24

795

6894

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

782

1.22

1.09

1.3

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

218

1.42

1.08

1.3

1.4

12.89

13.24

g/l

0.06

166

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

478

1.28

1.07

1.5

1.4

4.89

4.90

umol/l

0.01

423

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

648

1.24

1.07

6.3

4.1

52.31

55.77

u/ml

0.05

640

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.92

1.06

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

453

1.28

1.05

1.2

1.08

1.06

ratio

0.83

360

(3003888) Timothy IgE Ab [Units/volume] in Serum

150

1736

0.86

1.05

1.1

3.20

5.90

u/ml

2.61

988

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

121

0.50

1.05

1.0

1.2

0.20

6.50

u/ml

—

100

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

383

1.31

1.05

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

383

1.31

1.05

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

383

1.31

1.05

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

383

1.31

1.05

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

210

1853

1.14

1.04

5.2

4.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

146

1691

0.86

1.04

1.1

0.76

1.05

u/ml

0.42

825

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

191

2169

0.88

1.03

2.1

1.9

195.39

206.40

pmol/l

0.75

177

2057

(46235355) HIV 1 and 2 tests - Meaningful Use set

1617

15528

1.05

1.02

1.9

2.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

289

1.35

1.02

1.9

2.0

604.45

3382.19

e6/l

0.52

201

(3025941) Bacteria identified in Stool by Culture

467

4312

1.09

1.00

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

147

1.50

1.00

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

147

1.50

1.00

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

246

2200

1.12

1.00

2.1

2.3

0.00

g/l

-0.00

221

2067

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

180

1.45

1.00

1.5

1.6

0.31

0.38

ug/l

0.49

120

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

940

8906

1.06

0.98

4.7

4.9

32.47

32.34

0.13

672

6027

(3022621) pH of Urine by Test strip

670

6279

1.07

0.98

3.2

2.6

6.27

6.07

5.16

462

4233

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

606

0.77

0.98

1.2

1.3

199.38

183.30

pmol/l

0.15

606

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

283

1.34

0.97

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

811

1.20

0.97

1.2

69.37

70.78

u/l

0.05

706

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

6.58

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

178

1564

1.14

0.96

3.7

3.2

0.75

0.82

nmol/l

2.28

139

1248

(3023430) Cat dander IgE Ab [Units/volume] in Serum

110

1293

0.85

0.96

1.1

5.84

5.38

u/ml

0.07

619

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

944

0.82

0.94

1.6

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.77

0.94

1.2

2.34

1.64

umol/24h

0.59

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1355

12994

1.05

0.92

1.7

—

(21494434) Karyotype in Bone marrow

698

1.20

0.91

1.3

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

404

3726

1.09

0.91

1.3

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

227

1.37

0.90

1.1

1.3

16.10

16.37

umol/l

0.11

200

(3050794) Legionella sp Ab [Presence] in Serum

1.69

0.88

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

647

1.21

0.87

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

629

1.21

0.87

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

521

1.23

0.86

1.7

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

360

1.28

0.86

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.63

0.84

1.2

1.0

—

(3034891) Synovial lining cells/cells in Synovial fluid

355

0.73

0.84

1.6

1.5

4.80

3.99

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

129

1.47

0.83

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

111

956

1.16

0.83

1.5

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

435

1.24

0.81

1.4

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

435

1.24

0.81

1.4

1.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.61

0.81

3.7

3.3

0.81

1.43

mg/l

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

260

0.69

0.81

1.0

15.56

10.41

u/ml

0.33

177

(3024980) IgG subclass 4 [Mass/volume] in Serum

160

1418

1.13

0.80

1.6

0.71

0.78

g/l

0.43

127

1108

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

700

1.19

0.80

5.2

5.3

106.60

87.45

u/ml

0.10

222

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

463

1.23

0.80

1.8

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

147

1.43

0.79

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

312

1.28

0.78

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

407

0.76

0.78

5.5

4.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.51

0.77

1.0

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.1

—

0.21

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

160

1423

1.13

0.77

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

461

0.78

0.76

1.4

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

104

1199

0.87

0.76

1.3

1.2

—

(40762887) Creatinine [Moles/volume] in Blood

1.70

0.75

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.70

0.75

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

680

0.82

0.75

3.2

3.1

90.03

57.76

mg/l

0.29

520

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.64

0.75

2.3

1.8

1.16

0.85

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.64

0.75

2.3

1.8

3.58

1.37

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.64

0.75

2.3

1.8

0.86

0.89

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.64

0.75

2.3

1.8

1.34

1.67

mg/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.60

0.74

1.0

1.1

0.04

0.03

u/ml

0.56

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1029

10715

0.95

0.73

1.4

1.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.00

0.72

3.2

5.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

644

1.18

0.72

1.9

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3878

38118

1.03

0.71

3.3

3.2

141.62

124.51

ug/l

2.43

3604

35673

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

626

1.18

0.71

1.7

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.62

0.71

1.2

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

317

1.26

0.71

1.4

1.8

40.45

40.07

g/l

0.15

317

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

588

0.82

0.71

1.1

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

134

1.42

0.71

3.0

3.2

29.64

36.94

mg/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.92

0.70

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

109

1.47

0.70

1.2

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

102

887

1.15

0.70

1.3

1.4

0.39

0.40

g/l

0.08

640

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

664

1.18

0.70

1.2

—

(3035880) pH of Pleural fluid

444

1.22

0.70

1.2

1.3

7.43

7.41

0.25

299

(3018333) Ribosomal P Ab [Presence] in Serum

600

1.18

0.70

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

101

1.49

0.70

1.4

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

102

888

1.15

0.69

1.3

1.4

2.82

2.91

g/l

0.16

643

(3027135) IgG subclass 1 [Mass/volume] in Serum

102

888

1.15

0.69

1.3

1.4

6.67

6.68

g/l

0.00

640

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

432

0.79

0.69

4.3

2.4

197.65

200.45

u/l

0.12

426

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

262

2845

0.92

0.69

1.9

48.10

40.84

nmol/l

2.56

257

2771

(40768793) Breast Pathology biopsy report

145

1622

0.89

0.69

1.3

—

(44806420) Estimation of glomerular filtration rate

835

0.85

0.69

2.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

805

1.16

0.68

1.9

2.1

—

(40758358) Immune stain study

1.85

0.68

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

213

1.31

0.68

1.4

1.3

59.05

54.90

0.22

178

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

200

1818

1.10

0.67

1.4

1.2

3.14

3.79

u/ml

0.15

116

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

299

2768

1.08

0.67

5.2

5.7

1.50

1.49

mg/l

0.09

269

2558

(3008116) Ketones [Moles/volume] in Urine by Test strip

187

1.34

0.67

1.5

1.4

0.22

0.35

mmol/l

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

119

0.59

0.67

1.0

1.2

3.83

7.84

u/ml

—

100

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

483

1.20

0.67

1.8

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

474

0.80

0.67

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.63

0.66

1.0

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

249

1.29

0.66

1.6

1.8

13508.90

14964.68

e6/l

0.04

133

(3016650) Hepatitis A virus Ab [Presence] in Serum

157

1411

1.11

0.66

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

818

1.15

0.65

1.5

1.3

1.59

1.50

nmol/l

0.34

737

(3009508) Creatinine [Moles/volume] in Urine

2687

27423

0.97

0.65

3.5

3.6

7.53

7.74

mmol/l

1.42

2301

23392

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

623

1.17

0.65

1.2

—

(4062490) Immunoglobulin typing, IgG

100

875

1.14

0.65

1.4

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.57

0.65

2.3

1.8

1.06

1.13

mg/l

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.61

0.65

1.0

2.6

—

85.38

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

210

1919

1.10

0.65

1.2

1.4

24.18

55.89

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

180

1.33

0.64

1.3

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

792

1.15

0.64

1.4

1.2

27.43

40.67

u/ml

—

(3045142) Bone marrow Pathology biopsy report

105

924

1.14

0.63

1.3

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

616

1.17

0.63

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

425

3999

1.07

0.63

2.4

—

(3025130) Human papilloma virus identified in Specimen

1050

0.87

0.62

1.7

1.9

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.59

0.61

1.3

1.1

17.50

14.73

u/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1027

0.87

0.61

1.2

1.5

2.77

4.48

ug/l

2.45

922

(3034274) Bile acid [Moles/volume] in Serum --fasting

1068

0.88

0.60

2.1

2.7

5.26

7.82

umol/l

1.61

792

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

472

1.19

0.59

1.3

1.2

144.00

92.06

u/l

1.16

393

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

640

1.16

0.58

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

282

1.24

0.57

1.4

1.2

0.30

g/l

0.11

228

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

641

1.16

0.57

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

920

9540

0.96

0.57

2.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

615

0.84

0.57

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

275

0.76

0.56

1.5

1.6

0.48

0.51

e9/l

0.23

275

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

386

0.80

0.56

2.0

130.63

165.04

ug/min

—

(3001556) Androgen free Index in Serum or Plasma

0.58

0.56

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

458

1.18

0.55

1.3

1.2

31.35

26.82

u/l

0.17

374

(3036071) Salmonella sp Ab [Titer] in Serum

257

1.25

0.55

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

694

6654

1.05

0.54

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

235

2181

1.08

0.54

1.4

1.3

4.29

4.85

u/ml

0.10

195

(3010144) Erythrocytes [#/volume] in Synovial fluid

711

1.14

0.53

1.5

1.4

115906.75

128552.33

e6/l

0.07

470

(3020393) Adenovirus Ag [Presence] in Stool

151

1.32

0.53

1.5

1.6

—

(4146454) Self-monitoring of blood glucose

813

0.87

0.53

2.6

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

300

2812

1.07

0.53

2.1

1.8

—

32.21

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.52

0.52

1.0

1.1

108.80

97.45

titre

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

507

1.16

0.52

1.8

1.5

70.36

82.72

umol/l

4.17

507

(3036782) Glucose [Moles/volume] in Pleural fluid

826

1.13

0.52

1.3

1.4

5.94

6.36

mmol/l

1.00

770

(3000285) Sodium [Moles/volume] in Blood

152

1.32

0.51

1.3

1.2

133.00

138.89

mmol/l

1.73

123

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.38

0.50

1.9

1.6

55.89

44.95

umol/l

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

640

1.14

0.50

1.1

286.62

284.73

mg/l

0.07

584

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

412

0.82

0.50

2.0

1.9

27.60

382.35

pmol/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

674

6477

1.04

0.49

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

101

1.39

0.49

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

356

0.81

0.48

1.2

8.52

9.79

mm/h

0.31

356

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

155

0.71

0.48

2.5

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

308

1.20

0.47

1.0

1.1

1.42

6.42

u/ml

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.49

0.47

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

541

1.15

0.46

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

429

1.17

0.46

1.2

1.1

23.40

26.30

u/l

0.19

382

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

193

2075

0.93

0.46

1.1

3.96

8.05

eliau/ml

1.05

256

(3047189) Immunofixation for 24 hour Urine

386

0.83

0.46

1.2

1.7

—

(4211845) Urine protein measurement

383

1.18

0.46

2.2

3.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

196

1824

1.08

0.45

1.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.40

0.45

1.4

1.2

63.29

1535.33

u/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

219

1.23

0.44

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

233

2183

1.07

0.44

1.4

1.3

18.35

8.33

u/ml

0.79

310

(3049717) Cytology report of Urine Cyto stain

314

2973

1.06

0.43

2.3

2.8

—

(3000012) Reticulocyte production index

132

1211

1.09

0.43

2.2

2.1

1.01

0.89

1.63

801

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

193

1800

1.07

0.42

1.2

1.4

248.98

257.51

u/ml

0.19

120

1096

(3023323) Follitropin [Units/volume] in Serum or Plasma

401

3825

1.05

0.42

1.5

28.91

24.98

iu/l

1.41

330

3170

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.43

0.42

1.0

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.66

0.42

1.0

4.15

0.11

u/ml

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.65

0.42

1.2

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.64

0.42

1.0

1.2

2.21

0.29

u/ml

—

(4212803) Bone marrow aspirate examination

1.43

0.41

1.1

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.51

0.41

1.2

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.41

0.0

1.1

—

70.42

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

661

1.12

0.41

1.4

1.2

66.00

79.35

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

178

1659

1.07

0.41

1.5

1.6

138.01

146.26

au/ml

0.32

497

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.02

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

192

1797

1.07

0.39

2.6

2.4

188.39

105.88

ug/min

1.55

109

1094

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

103

0.68

0.39

1.0

1.1

3.34

6.54

u/ml

—

103

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

155

1440

1.08

0.39

1.1

8.86

17.84

au/ml

2.06

331

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.43

0.39

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

665

0.89

0.39

1.2

108.97

105.81

pmol/l

0.14

665

(4133840) Spirometry

215

0.79

0.39

1.4

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

178

1.24

0.38

1.8

2.0

0.08

0.19

nmol/l

1.67

131

(3024471) HLA-A [Type]

261

1.19

0.38

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

147

0.75

0.37

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

743

1.10

0.37

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

534

1.12

0.36

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

347

1.15

0.35

2.3

3.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4966

49256

1.02

0.35

3.2

3.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6329

63614

0.98

0.35

29.4

19.9

13.63

13.61

0.53

6277

62770

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.36

0.34

1.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

537

1.12

0.34

1.4

1.3

113.33

464.77

titre

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

623

1.11

0.34

1.4

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

566

1.11

0.34

1.4

1.2

48.37

46.20

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

297

0.84

0.33

1.9

1.7

2704.00

3000.00

titre

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.33

0.33

1.0

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

340

1.15

0.33

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

577

1.11

0.33

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

146

1.23

0.32

6.0

7.5

10.16

10.41

0.18

146

(3024932) HLA-DR beta [Type]

257

1.17

0.31

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

279

2914

0.96

0.30

1.6

1.7

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.71

0.30

19.9

8.7

0.21

0.19

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

300

2877

1.04

0.29

3.2

3.6

157.54

2384.27

u/ml

1.55

262

2474

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

222

2329

0.95

0.29

1.5

—

(3006270) Folate [Moles/volume] in Blood

630

1.10

0.29

1.1

1.2

311.16

357.80

nmol/l

1.22

530

(40761995) Spermatozoa Progressive [#/volume] in Semen

241

1.16

0.28

2.4

3.3

41.39

44.56

0.28

241

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6461

64293

1.02

0.28

31.9

20.5

334.14

332.58

g/l

34.00

6416

63903

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

140

1.21

0.27

1.3

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

451

1.11

0.27

1.7

1.5

1.18

1.21

nmol/l

0.09

330

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

1162

0.94

0.26

1.1

1.66

2.89

0.72

171

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

645

0.91

0.26

1.1

9.39

9.21

iu/ml

0.02

161

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.28

0.26

2.0

4.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

169

1.18

0.25

1.2

1.82

1.57

mmol/l

0.50

108

(3006571) Granulocytes/Leukocytes in Synovial fluid

881

0.93

0.25

1.8

1.5

57.30

59.04

0.17

560

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

243

2336

1.04

0.24

1.4

1.3

44.36

35.11

u/ml

0.23

120

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

174

1822

0.95

0.24

1.2

1.3

—

(3007463) Buprenorphine [Presence] in Urine

1.32

0.23

3.4

6.2

—

(3022670) pH of Venous cord blood

1.32

0.23

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

171

1.17

0.23

1.0

1.3

1.17

mmol/l

0.08

171

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

466

1.09

0.23

1.5

6.89

6.73

u/l

0.04

373

(40768443) Skin Pathology biopsy report

365

3540

1.03

0.23

1.2

—

(40768795) Lymph node Pathology biopsy report

784

0.93

0.22

1.1

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.74

0.22

1.1

—

(4015189) Microbial culture of sputum

178

0.84

0.22

1.5

2.2

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.03

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.0

—

0.27

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

325

0.89

0.21

1.0

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

119

1129

1.05

0.21

1.1

1.47

1.50

g/l

0.40

110

1026

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

10.53

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

6.9

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40768441) Liver Pathology biopsy report

595

1.08

0.20

1.6

1.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

230

1.13

0.20

1.7

2.8

250.08

111.47

ng/l

0.47

156

(3005322) IgE [Units/volume] in Serum or Plasma

548

5359

1.02

0.20

1.4

1.3

162.96

270.55

u/ml

3.11

506

5000

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.20

0.0

1.1

—

35.16

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.20

0.0

1.1

—

(3014891) Appearance of Pleural fluid

108

1.20

0.20

1.8

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

664

1.07

0.20

1.2

1.4

82.17

77.68

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

157

1637

0.96

0.19

5.0

3.5

26.98

27.97

mg/l

0.13

112

1144

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

197

0.86

0.19

1.0

1.1

30.89

40.03

iu/ml

0.34

197

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

241

1.12

0.19

5.0

6.6

8.59

8.42

0.05

241

(3048929) Epstein Barr virus Ab [Presence] in Serum

301

2925

1.03

0.18

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

109

1037

1.05

0.18

1.9

2.4

1.56

1.34

g/24h

0.42

616

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

218

2108

1.03

0.18

1.9

2.0

3.09

6.45

iu/l

0.67

870

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

271

2789

0.97

0.18

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

630

1.06

0.17

2.4

2.6

27.29

29.33

mg/l

0.15

451

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.76

0.17

1.0

7.89

2.31

u/ml

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

718

1.06

0.17

1.3

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

598

0.94

0.16

1.3

2.73

3.43

u/ml

0.11

351

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

865

8768

0.98

0.16

2.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.13

0.16

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

161

1667

0.96

0.16

3.3

3.6

931.91

855.34

u/ml

0.04

147

1522

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

193

0.88

0.15

1.4

1.3

24.50

36.99

1.41

130

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.79

0.15

1.7

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.76

0.15

2.7

4.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

121

1.16

0.15

2.5

1.9

97.93

40.29

pmol/l

0.48

100

(43055442) Apixaban [Mass/volume] in Serum or Plasma

140

1.14

0.15

1.5

1.6

98.39

120.58

ug/l

—

120

(3025577) Chromium [Mass/volume] in Blood

430

0.93

0.14

2.2

3.88

2.35

ug/l

0.34

357

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.79

0.14

1.1

1.2

5.86

5.83

mmol/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.79

0.14

1.6

1.5

—

(44806071) Cardiolipin IgM antibody measurement

112

1.16

0.14

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

218

2121

1.03

0.14

1.3

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

675

0.95

0.14

1.6

1.5

32.29

29.93

0.22

413

(3005011) Chlamydia sp Ab [Titer] in Serum

122

1.15

0.13

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

441

1.07

0.13

7.8

7.1

16.91

96.74

ug/l

0.96

294

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

171

1.11

0.12

1.4

1.1

20.46

20.18

mmol/l

0.09

151

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

168

1635

1.03

0.11

2.5

2.0

0.95

0.83

nmol/l

1.09

135

1387

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

493

1.05

0.11

1.3

1.5

10.91

6.12

u/l

0.57

428

(37208534) Antinuclear antibody arbitrary concentration in serum

271

0.92

0.11

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

240

0.92

0.11

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

964

0.96

0.11

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

193

1975

0.98

0.11

1.8

1.6

12380.84

14692.61

e6/l

0.47

134

1380

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

679

0.96

0.11

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

359

3530

1.02

0.11

3.2

3.6

139.46

64.59

u/ml

0.43

348

3409

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7111

71196

0.99

0.10

22.8

15.8

86.45

81.66

ml/min/173m2

62.08

6674

65622

(3016750) Collection duration of Urine

417

1.05

0.10

2.5

2.3

497.43

494.09

min

0.07

309

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

771

1.04

0.10

3.1

3.7

—

(3000330) Specific gravity of Urine by Test strip

404

3984

1.01

0.09

4.0

3.4

1.02

ratio

0.58

368

3587

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

254

2584

0.98

0.09

1.4

1.3

185.91

222.48

miu/ml

0.83

1159

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.11

0.09

2.3

3.6

—

(3020650) Glucose [Presence] in Urine

257

0.93

0.08

1.2

1.7

0.00

0.02

estimate

0.80

257

(3044007) Cell count panel - Peritoneal fluid

253

1.07

0.08

1.5

1.9

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.83

0.08

1.4

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.82

0.08

3.2

5.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.82

0.08

1.2

1.1

0.00

3.09

u/ml

—

(3001729) Color of Synovial fluid

0.78

0.08

1.0

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.78

0.08

2.8

6.0

—

(3014051) Protein [Presence] in Urine by Test strip

2283

22724

1.01

0.08

3.3

3.0

0.10

0.06

0.27

537

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

409

0.95

0.08

1.2

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

1053

10594

0.99

0.07

2.3

2.6

152.96

132.01

ug/g

0.81

825

8506

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

270

2661

1.01

0.07

1.5

20.79

6.49

iu/ml

0.36

500

(3027035) Albumin [Mass/time] in 24 hour Urine

1.05

0.07

1.4

1.3

—

577.74

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

479

0.96

0.07

2.0

94.53

112.43

ng/l

1.03

479

(3051101) Glucose [Moles/volume] in Cord blood

122

0.90

0.07

6.7

7.0

8.78

8.27

mmol/l

0.22

122

(3004775) Volume in Urine collected for unspecified duration

580

1.03

0.07

2.3

707.68

637.86

0.61

386

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.12

0.06

1.2

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

591

1.03

0.06

2.3

3.3

23.11

24.93

mu/l

0.21

562

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

418

4141

1.01

0.06

1.1

1.17

9.32

u/ml

—

(3042733) HLA Ab [Presence] in Serum

286

1.05

0.05

5.0

4.5

—

(40765096) Chromosome analysis panel by Banding

253

0.95

0.05

1.1

—

(3048879) Bone marrow aspiration report

198

1.06

0.05

2.1

1.9

—

2.00

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

110

0.91

0.05

11.1

12.3

4.92

5.64

mmol/l

—

110

(3043410) Blood group antigens tested for on Red Blood Cells

218

1.05

0.05

1.9

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

120

0.92

0.05

1.1

1.2

78.45

67.39

ug/l

0.28

120

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

189

1.06

0.04

1.6

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

180

0.94

0.04

1.1

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

291

0.96

0.04

2.8

3.4

102.33

128.85

au/ml

—

(40768797) Stomach Pathology biopsy report

1069

10719

1.00

0.03

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

440

4377

1.01

0.03

1.0

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

110

1087

1.01

0.02

1.3

1.2

25.52

14.12

u/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

208

0.96

0.02

5.7

6.9

4.92

5.28

kpa

0.86

208

(3019832) Treponema pallidum Ab [Presence] in Serum

819

8205

1.00

0.02

1.7

1.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

452

1.02

0.01

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

233

1.03

0.01

1.3

1.2

39.02

39.16

g/l

0.02

122

(3024263) Appearance of Synovial fluid

397

0.98

0.01

1.5

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

146

1465

1.00

0.00

1.4

1.3

56.56

34.57

u/l

0.67

129

1275

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.03

0.00

1.3

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

210

1.00

0.00

3.2

3.0

—

(3006598) pH of Arterial cord blood

134

0.97

0.00

1.0

—

(3002619) Bacteria identified in Specimen by Culture

203

0.98

0.00

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

105

1.05

0.00

1.2

—

(40758292) HTLV I+II Ab panel - Serum

164

0.98

0.00

1.4

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

227

1.01

0.00

1.1

1.3

13.18

13.92

pmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

216

1.02

0.00

1.4

1.6

11.47

9.10

ug/l

0.85

216

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

144

0.97

0.00

1.1

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

228

1.01

0.00

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

228

1.01

0.00

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

228

1.01

0.00

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

228

1.01

0.00

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

175

1745

1.00

0.00

1.3

1.2

61.27

39.98

u/ml

0.70

159

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

15.67

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.94

-0.00

1.2

1.5

268.80

318.21

umol/24h

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.86

-0.00

1.0

165.40

165.34

g/l

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

51.71

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.96

-0.00

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.93

-0.00

1.0

1.1

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.6

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.2

—

0.07

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

-0.00

5.0

4.7

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.00

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.00

-0.00

1.5

2.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.3

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: FE_MODE – Focal epilepsy, mode (most common among epilepsy diagnosis)

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Focal epilepsy, mode (most common among epilepsy diagnosis)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Focal epilepsy, mode (most common among epilepsy diagnosis) (FE_MODE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints